{"study_id": 114829, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify molecular changes in human liver during NAFLD progression using gene expression analysis of liver biopsies and bariatric surgery samples.", "results_summary": "The study identified a reproducible gene expression signature associated with NAFLD progression, including novel genes like HORMAD2 and LINC01554, and highlighted potential biomarkers and known drugs for further study.", "population_specificity": "NAFLD patients who underwent liver biopsies or bariatric surgery.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:36.473206+00:00"}
{"study_id": 114830, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to systematically review the literature on food addiction among bariatric surgery patients, focusing on associated features and prognostic significance.", "results_summary": "Pre-surgical food addiction was not linked to weight outcomes but was associated with broader psychopathology; the relationship with substance misuse was mixed, and methodological limitations were noted.", "population_specificity": "Individuals seeking or having undergone bariatric surgery.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:37.417257+00:00"}
{"study_id": 114832, "supplement_id": 913, "safety_score": "70", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the prevalence of NASH in obese patients undergoing bariatric surgery, evaluate the performance of noninvasive markers for NASH, and assess complications of intraoperative liver biopsy.", "results_summary": "The meta-analysis found an overall NASH prevalence of 25% with high heterogeneity across studies. Noninvasive markers alone were ineffective in discriminating between normal liver and NASH, while intraoperative biopsy was associated with some complications.", "population_specificity": "Obese patients undergoing bariatric surgery.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:37.836612+00:00"}
{"study_id": 114831, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to review the limitations of conventional obesity treatments (diet, exercise, bariatric surgery) and evaluate the role of pharmacological tools as a second-line therapy.", "results_summary": "The abstract highlights that bariatric surgery has limitations, prompting the need for pharmacological options. It notes that three drugs are approved by EMA and FDA for obesity therapy, with two more authorized only by FDA, and emphasizes individualized treatment selection based on factors like safety and efficacy.", "population_specificity": "Not specified (general obesity treatment context).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:38.461998+00:00"}
{"study_id": 114833, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 68, "study_goal": "The researchers aimed to evaluate alterations in gut hormones during diet-induced weight loss, maintenance, and regain, and compare these changes to those seen with bariatric surgery and other treatments.", "results_summary": "The study found significant alterations in gut hormones (e.g., decreased PYY, GLP-1, and increased ghrelin) during weight loss, with persistent changes linked to appetite and weight regain. Differences between diet-induced changes and those from bariatric surgery were noted, but methodological heterogeneity limits definitive conclusions.", "population_specificity": "656 participants across 16 studies (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:39.358223+00:00"}
{"study_id": 114834, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the mechanisms by which bariatric surgery modulates brain function to control body weight and comorbidities in obese patients.", "results_summary": "The study found that bariatric surgery alters gut peptide secretion and vagal nerve stimulation, leading to reduced food intake and improved weight-related diseases. It also affects hormones like leptin and adiponectin, and modifies hedonistic behavior and cognitive performance related to food intake.", "population_specificity": "Moderately or morbidly obese patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:41.575390+00:00"}
{"study_id": 114835, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the long-term durability of weight loss and the effectiveness of Roux-en-Y gastric bypass in remitting and preventing type 2 diabetes, hypertension, and dyslipidemia over a 12-year period.", "results_summary": "The study found significant long-term weight loss in the surgery group (-35.0 kg at 12 years) compared to nonsurgery groups, with higher remission rates for type 2 diabetes (51% at 12 years) and lower incidence rates of hypertension and dyslipidemia. The surgery group also showed significantly reduced odds of developing type 2 diabetes compared to nonsurgery groups.", "population_specificity": "1156 patients with severe obesity, divided into surgery and nonsurgery groups.", "effective_dosage": "Not applicable (surgical intervention).", "study_duration": "12-year follow-up.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:44.154149+00:00"}
{"study_id": 114836, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 65, "study_goal": "The researchers aimed to identify and compare effective obesity management strategies, including bariatric surgery, for individuals with chronic spinal cord injury (SCI).", "results_summary": "Bariatric surgery produced the greatest permanent weight reduction and BMI correction among the studied interventions, outperforming combinations of physical exercise and diet therapy.", "population_specificity": "Individuals with chronic spinal cord injury (SCI) susceptible to central and visceral obesity.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:44.825709+00:00"}
{"study_id": 114839, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to understand the mechanism behind lower serum vitamin D levels in obese individuals and whether bariatric surgery affects bone health in these patients.", "results_summary": "The study found that lower vitamin D levels in obese individuals likely result from volumetric dilution rather than clinical deficiency. Bariatric surgery patients experience bone loss, but ensuring vitamin D sufficiency may help mitigate this effect.", "population_specificity": "Obese individuals, including those undergoing bariatric surgery.", "effective_dosage": "Higher loading doses of vitamin D are needed for obese individuals to achieve normal serum levels (specific dosage not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:47.141841+00:00"}
{"study_id": 114840, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to investigate the preoperative nutritional management practices of Australian dietitians for bariatric surgery patients.", "results_summary": "Most dietitians recommended very-low-energy diets with liquid meal replacements for preoperative weight loss. Private practitioners more frequently involved bariatric surgeons in multidisciplinary teams and provided more comprehensive education compared to public sector dietitians. Preoperative screening practices were inconsistent with current guidelines.", "population_specificity": "Australian dietitians managing bariatric surgery patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:47.207373+00:00"}
{"study_id": 114838, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the alterations in gut microbiota after bariatric surgery and its correlations with host metabolism.", "results_summary": "The study found significant changes in gut microbiota post-surgery, including increases in Bacteroidetes, Fusobacteria, Verrucomicrobia, and Proteobacteria, and decreases in Firmicutes and related species. These changes were linked to metabolic outcomes like body composition and glucose homeostasis, though microbial diversity changes remain debated.", "population_specificity": "Patients with obesity and type 2 diabetes (clinical studies) and animal models (animal experiments).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:47.268583+00:00"}
{"study_id": 114841, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the necessity of routine endoscopy and H. pylori eradication before bariatric surgery and its potential role in postoperative complications.", "results_summary": "The study found that while some evidence supports preoperative upper endoscopy and H. pylori eradication, the prevalence of H. pylori infection before surgery mirrors general regional rates, and the role of H. pylori in postoperative complications remains unclear.", "population_specificity": "Patients undergoing bariatric surgery, with a focus on H. pylori infection prevalence.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:47.462642+00:00"}
{"study_id": 114837, "supplement_id": 913, "safety_score": "65", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to examine the prevalence of secondary hyperparathyroidism (SHPT) in obese subjects after different bariatric surgeries and identify predictors of SHPT.", "results_summary": "The study found a high prevalence of SHPT in morbidly obese patients before surgery, which increased post-surgery, particularly in those undergoing single anastomosis gastric bypass (SAGB). Vitamin D deficiency was a key predictor of SHPT pre-surgery, while age, sex, calcium levels, and bypass procedures influenced SHPT post-surgery.", "population_specificity": "1470 obese subjects undergoing bariatric/metabolic surgery, including Roux-en-Y gastric bypass (RYGB), single anastomosis gastric bypass (SAGB), laparoscopic adjustable gastric banding (LAGB), and sleeve gastrectomy (SG).", "effective_dosage": "Not specified", "study_duration": "1-year follow-up for all patients, with 5-year data available for 215 patients.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:47.949355+00:00"}
{"study_id": 114842, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness and physiological mechanisms of bariatric surgery, including RYGB, AGB, and SG, in achieving durable weight loss and metabolic improvements.", "results_summary": "Bariatric surgery, particularly SG, has become increasingly popular and is effective for durable weight loss. The procedures induce profound physiological changes, including alterations in gut hormones and vagus nerve activity, which reduce appetite and food intake. The exact pathways and sufficiency of vagally-mediated circuits in driving metabolic effects remain unclear.", "population_specificity": "Morbidly obese patients (human and animal models).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:51.356417+00:00"}
{"study_id": 114843, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the current state of bariatric endoscopy, its clinical outcomes, and its role in bridging the gap between lifestyle/pharmaceutical treatments and bariatric surgery for obesity.", "results_summary": "The study highlights that bariatric endoscopic therapy is a minimally invasive option with potential benefits in weight loss, metabolic profile improvement, and comorbidity reduction, appealing to patients resistant to surgery or early in obesity onset. Five FDA-approved endoscopic devices are discussed, with many more in development or clinical trials.", "population_specificity": "Obese individuals, particularly those resistant to surgery or early in obesity onset.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:53.507345+00:00"}
{"study_id": 114844, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to explore the role of nutritional genomics in personalized bariatric surgery outcomes and its impact on genetic, epigenetic, and metabolic pathways.", "results_summary": "The study found that bariatric surgery influences nutrigenetics, nutrigenomics, and epigenetics, with genetic and epigenetic variables affecting weight loss outcomes. It also demonstrated associations between single nucleotide polymorphisms and obesity phenotypes, as well as changes in telomere length and gut microbial communities post-surgery.", "population_specificity": "Patients undergoing bariatric surgery (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:53.589510+00:00"}
{"study_id": 114848, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review potential mechanisms by which bariatric surgery contributes to weight loss and improved metabolic health.", "results_summary": "The study highlights bariatric surgery as an effective intervention for sustained weight loss and metabolic improvements, emphasizing the role of the gastrointestinal tract, bile acid physiology, gut hormones, and the microbiome. However, the exact cellular and physiological mechanisms remain unclear.", "population_specificity": "Not specified (review article)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:55.391468+00:00"}
{"study_id": 114847, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effectiveness of bariatric surgery in adolescents with severe and morbid obesity, particularly focusing on BMI reduction.", "results_summary": "The study found that bariatric surgery, specifically gastric banding, resulted in an average BMI loss of 11.6 kg/m\u00b2 in adolescents with severe and morbid obesity, demonstrating short-term effectiveness. Lifestyle interventions were noted to have limited effectiveness in children and none in adolescents.", "population_specificity": "Obese adolescents in France with severe obesity (BMI >120% of IOTF-30 cutoff) or morbid obesity (BMI >140% of IOTF-30 cutoff).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:56.336381+00:00"}
{"study_id": 114845, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the role of bariatric surgery in managing non-alcoholic steatohepatitis (NASH) in morbidly obese patients unresponsive to lifestyle interventions and weight-loss drugs.", "results_summary": "The abstract suggests bariatric surgery is reserved for morbidly obese patients who fail lifestyle and pharmacological interventions, implying it may be effective for weight loss and metabolic restitution in this population. However, specific outcomes or data on efficacy are not detailed.", "population_specificity": "Morbidly obese patients with non-alcoholic steatohepatitis (NASH) unresponsive to lifestyle and drug therapies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:56.401715+00:00"}
{"study_id": 114846, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of gut hormones in regulating food intake and energy homeostasis, particularly focusing on the long-term benefits of bariatric surgery in obesity treatment.", "results_summary": "The study highlights that bariatric surgery is the most effective treatment for obesity, with long-term benefits potentially linked to increased activity of gut hormones like peptide YY3-36 and glucagon-like peptide 1. It also discusses the involvement of gut-brain signaling in body weight regulation.", "population_specificity": "Not specified (general obesity context, possibly including children, adolescents, and adults).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:56.505660+00:00"}
{"study_id": 114849, "supplement_id": 913, "safety_score": "60", "efficacy_score": 70, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the benefits and harms of weight loss, including bariatric surgery, on serum uric acid levels and gout attacks in overweight/obese patients with gout.", "results_summary": "Bariatric surgery showed mixed effects, with temporary increases in serum uric acid and gout attacks in the short term, but potential long-term benefits were not clearly established due to limited data.", "population_specificity": "Overweight and obese patients with gout.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:00:57.633733+00:00"}
{"study_id": 114850, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness of standard versus distal Roux-en-Y gastric bypass (RYGB) in improving obesity-related quality of life, weight loss, and psychological outcomes in morbidly obese patients.", "results_summary": "Both standard and distal RYGB significantly improved obesity-related quality of life and reduced weight-related symptoms, with no statistically significant differences between the two procedures. There were also no significant differences in uncontrolled eating, cognitive restraint, emotional eating, anxiety, or depression rates between the groups.", "population_specificity": "113 patients with BMI between 50 and 60.", "effective_dosage": "Not specified (surgical procedure).", "study_duration": "2 years post-surgery.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:01.272709+00:00"}
{"study_id": 114851, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "To study the occurrence and level of diabetic retinopathy (DRP) before and after bariatric surgery and identify risk factors for DRP deterioration.", "results_summary": "In most patients, no DRP deterioration was observed after gastric bypass surgery. Pre-surgery DRP screening is recommended for diabetic patients undergoing bariatric surgery.", "population_specificity": "Diabetic patients who underwent gastric bypass surgery in Sweden (2008-2010).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:01.412045+00:00"}
{"study_id": 114852, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to investigate the molecular mechanisms of UDCA in regulating ER homeostasis, apoptosis, and oxidative stress in morbidly obese NAFLD patients undergoing bariatric surgery.", "results_summary": "UDCA treatment increased SAF-scores and elevated CHOP levels but did not induce apoptosis or improve oxidative stress. The study found ambivalent effects, with potential cytoprotective properties altering the apoptotic threshold.", "population_specificity": "40 well-matched morbidly obese NAFLD patients undergoing bariatric surgery.", "effective_dosage": "20 mg/kg/d", "study_duration": "3 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:02.713984+00:00"}
{"study_id": 114853, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to identify psychosocial characteristics associated with behavioral weight loss success among bariatric surgery candidates to inform optimal patient selection.", "results_summary": "The study found that social support was strongly correlated with behavioral weight loss success in bariatric surgery candidates, suggesting its importance in pre-surgical interventions. Weight loss during the 16-week induction phase was analyzed, with results indicating significant associations between baseline characteristics and outcomes.", "population_specificity": "Veterans with severe obesity meeting NIH criteria for bariatric surgery (BMI 35.0-39.9 with comorbidities or BMI \u2265 40).", "effective_dosage": "Not specified", "study_duration": "16 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:04.241167+00:00"}
{"study_id": 114854, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compile studies from 2012-2017 on how metabolic and bariatric surgery affects DNA methylation patterns and its association with metabolic improvements in obesity.", "results_summary": "The studies showed that metabolic and bariatric surgery modifies the DNA methylation profile of genes linked to obesity pathophysiology, contributing to metabolic health benefits. Site-specific DNA methylation changes were observed, though global DNA methylation results were inconclusive.", "population_specificity": "Morbidly obese subjects, primarily women.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:05.143204+00:00"}
{"study_id": 114856, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to explore the role of bariatric surgery as a treatment option for metabolic syndrome (MetS) in high-risk cases, given the lack of consensus on its efficacy and safety.", "results_summary": "The abstract indicates that bariatric surgery is still considered contradictory and is only recommended in selected high-risk cases, suggesting limited or conditional efficacy. No specific outcomes or statistical results are provided regarding its effects.", "population_specificity": "High-risk cases of metabolic syndrome (adults, children, and adolescents).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:05.670628+00:00"}
{"study_id": 114855, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of probiotics versus placebo on hepatic, inflammatory, and clinical outcomes in patients who underwent laparoscopic sleeve gastrectomy (LSG).", "results_summary": "The study found that probiotics administration did not improve hepatic, inflammatory, or clinical outcomes at 6 and 12 months post-LSG. Secondary outcomes, including fibrosis, metabolic parameters, and quality of life, also showed no significant improvement.", "population_specificity": "100 morbidly obese nonalcoholic fatty liver disease (NAFLD) patients (60% women, mean age 41.9\u00b19.8 years, BMI 42.3\u00b14.7 kg/m\u00b2) who underwent LSG.", "effective_dosage": "Not specified", "study_duration": "6 months of treatment, followed by 6 months of additional follow-up.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:07.041557+00:00"}
{"study_id": 114857, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Roux-en-Y gastric bypass (RYGB) surgery significantly alters the bioavailability of venlafaxine ER capsules.", "results_summary": "The study found that RYGB did not significantly alter the absorption of venlafaxine or its active metabolite, ODV, from an ER capsule, nor did it affect the absorption timeframe.", "population_specificity": "Ten adult pre-bariatric surgery patients eligible for noncomplicated RYGB.", "effective_dosage": "One 75-mg venlafaxine ER capsule administered once before and once after surgery.", "study_duration": "Two single-dose administrations (pre-surgery and 3-4 months post-surgery).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:07.042965+00:00"}
{"study_id": 114860, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of bariatric surgery in reducing blood pressure and long-term cardiovascular risk in obese patients with hypertension.", "results_summary": "Bariatric surgery provided sustained weight loss, leading to significant reductions in blood pressure and attenuation of cardiovascular risk, outperforming lifestyle interventions which lacked long-term benefits.", "population_specificity": "Obese patients with hypertension, particularly those with resistant hypertension and risk of end organ damage.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:10.459418+00:00"}
{"study_id": 114859, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the effectiveness of laparoscopic sleeve gastrectomy (LSG) versus silastic ring laparoscopic Roux-en-Y gastric bypass (SR-LRYGB) in achieving remission of type 2 diabetes (T2D) among patients with morbid obesity.", "results_summary": "The study found that despite significantly greater weight loss after SR-LRYGB, both procedures resulted in similar T2D remission and psychosocial improvement at 1 year.", "population_specificity": "Patients aged 20-55 years with T2D of at least 6 months duration and BMI 35-65 kg/m\u00b2.", "effective_dosage": "Not applicable (surgical intervention)", "study_duration": "1 year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:11.163302+00:00"}
{"study_id": 114863, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to explore weight management strategies, including bariatric surgery, for patients with type 1 diabetes and obesity (\"double diabetes\").", "results_summary": "The abstract suggests bariatric surgery may be considered if medical weight reduction fails, but it does not provide specific outcomes or data on its effectiveness for this population.", "population_specificity": "Patients with type 1 diabetes and obesity (\"double diabetes\").", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:13.204924+00:00"}
{"study_id": 114858, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the outcomes of Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) in insulin-treated (I-T2D) versus non-insulin-treated (O-T2D) type 2 diabetes patients, focusing on weight loss, medication use, and remission rates.", "results_summary": "Both RYGB and SG led to significant weight loss, with similar results between insulin and non-insulin groups. RYGB showed greater reduction in insulin use and higher complete remission rates in I-T2D patients compared to SG, especially in earlier years.", "population_specificity": "3,668 diabetic patients (2,872 O-T2D and 1,187 I-T2D) from the Ontario Bariatric Registry who underwent surgery between 2010-2017.", "effective_dosage": "Not applicable (surgical intervention).", "study_duration": "3-year follow-up.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:13.522953+00:00"}
{"study_id": 114862, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the neuroendocrine regulation of energy balance in obesity and evaluate the effects of bariatric surgeries on weight loss and hormonal signaling.", "results_summary": "Bariatric surgeries promote sustained weight loss not only by reducing calorie intake but also by altering appetite control, satiation, and gut- and adipose-tissue-derived hormone signaling. The procedures are effective long-term interventions for severe obesity when conventional treatments fail.", "population_specificity": "Individuals with severe obesity (no further specificity provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:13.756165+00:00"}
{"study_id": 114861, "supplement_id": 913, "safety_score": "75", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to describe gender differences in bariatric surgery outcomes and explore physiologic and psychological factors contributing to the gender gap in utilization.", "results_summary": "Males had higher complication rates, lower weight loss, and reduced comorbidity resolution compared to females, yet reported significantly higher satisfaction and psychological well-being postoperatively. Females showed better physical outcomes but lower psychological satisfaction.", "population_specificity": "61,708 patients (22% male) from the Michigan Bariatric Surgery Collaborative undergoing primary bariatric surgery (2006\u20132016).", "effective_dosage": "Not Assessed", "study_duration": "1-year postoperative follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:13.823032+00:00"}
{"study_id": 114865, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to explore the role of the gastrointestinal tract in the metabolic changes observed after bariatric surgery, focusing on incretin-producing cells, glucose absorption, and intestinal permeability.", "results_summary": "The study suggests that changes in incretin-producing cells, glucose absorption rates, and reduced intestinal permeability contribute to improved metabolic outcomes post-bariatric surgery, opening new therapeutic possibilities.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:15.047334+00:00"}
{"study_id": 114864, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to investigate the feasibility of pre-surgical pulmonary rehabilitation (PR) in morbidly obese patients with uncontrolled asthma undergoing bariatric surgery.", "results_summary": "Patients who participated in PR showed dramatic improvement in asthma control and quality of life after 3 months, with better asthma control at the time of surgery compared to controls. The study suggests PR is feasible and beneficial for selected morbidly obese asthmatics before bariatric surgery.", "population_specificity": "Morbidly obese female patients with uncontrolled asthma undergoing bariatric surgery.", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:15.853241+00:00"}
{"study_id": 114867, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to explore the potential role of bariatric surgery as part of a multimodal approach for treating NAFLD in children.", "results_summary": "The abstract suggests bariatric surgery may be a future treatment option for NAFLD, though no specific results or data are provided regarding its efficacy or safety in this context.", "population_specificity": "Children with NAFLD (non-alcoholic fatty liver disease).", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:18.593635+00:00"}
{"study_id": 114866, "supplement_id": 913, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to examine the evidence for bariatric surgery in severely obese pediatric populations and assess its feasibility, safety, and efficacy compared to adult outcomes.", "results_summary": "The study found that adolescent bariatric surgery outcomes are comparable to adults, with sustainable weight loss, resolution of comorbidities, and similar complication rates. However, these results are primarily from specialized centers, suggesting reproducibility may depend on regulated environments and multidisciplinary teams.", "population_specificity": "Severely obese pediatric and adolescent populations.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:18.708318+00:00"}
{"study_id": 114868, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of gut hormones in the metabolic effects of bariatric surgery, particularly its impact on type 2 diabetes remission and sustained weight loss.", "results_summary": "Bariatric surgery significantly elevates gut hormone levels, leading to acute remission of type 2 diabetes before weight loss occurs. Long-term weight loss is sustained over weeks to months, prompting interest in developing gut hormone-based drugs for diabetes and obesity.", "population_specificity": "Not specified (abstract does not detail study population).", "effective_dosage": "Not specified.", "study_duration": "Long-term (weeks to months).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:21.427727+00:00"}
{"study_id": 114869, "supplement_id": 913, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the safety and feasibility of laparoscopic Nissen's fundoplication (LNF) combined with mid-gastric plication (MGP) for treating obese patients with GERD.", "results_summary": "The study found that LNF combined with MGP was safe, with no serious complications, and effective in resolving GERD symptoms and promoting significant weight loss. Patient satisfaction and endoscopic improvements were also noted at 6 and 12 months.", "population_specificity": "Obese patients with GERD (n=18).", "effective_dosage": "Not Assessed", "study_duration": "Follow-up ranged from 12 to 33 months (mean 17.74 months).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:23.116385+00:00"}
{"study_id": 114870, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the long-term (\u2265 5 years) outcomes of bariatric surgery on diabetes remission, microvascular and macrovascular events, and mortality among type 2 diabetes (T2D) patients.", "results_summary": "The study found that bariatric surgery significantly increased diabetes remission, reduced microvascular and macrovascular events, and lowered mortality compared to non-surgical treatment in T2D patients after at least 5 years of follow-up. Pooled estimates showed strong relative risk reductions across all measured outcomes.", "population_specificity": "Type 2 diabetes (T2D) patients.", "effective_dosage": "Not specified", "study_duration": "\u2265 5 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:23.459535+00:00"}
{"study_id": 114872, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate predictors of weight loss after bariatric surgery and the efficacy of cognitive behavioral therapy (CBT) in improving outcomes for bariatric patients.", "results_summary": "Postoperative disordered eating behaviors and depressive symptoms were associated with less optimal weight loss, while CBT showed promise in reducing these risk factors and promoting weight loss. New CBT delivery methods (telephone, internet, virtual reality) may improve accessibility.", "population_specificity": "Patients undergoing bariatric surgery, particularly those with disordered eating behaviors or depressive symptoms.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:23.911459+00:00"}
{"study_id": 114873, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the antidiabetic effects of laparoscopic sleeve gastrectomy (LSG) and LSG with duodenal-jejunal bypass (LSG/DJB) in Japanese obese diabetic patients.", "results_summary": "Both LSG and LSG/DJB showed high diabetes remission rates (80.8% and 86.0%, respectively) at 12 months. LSG/DJB was more effective for patients with lower ABCD scores, while no difference was observed in patients with higher ABCD scores.", "population_specificity": "Japanese obese patients with type 2 diabetes.", "effective_dosage": "Not applicable (surgical procedures).", "study_duration": "12 months post-surgery.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:25.731442+00:00"}
{"study_id": 114875, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the clinical impact of studies from large US databases concerning outcomes of bariatric surgery.", "results_summary": "The review included 54 studies, categorizing outcomes into surgical techniques, morbidity/mortality, 30-day readmission, disease-specific outcomes, training, and socio-economic/ethnic observations. Large databases provided complementary information for external validation and evaluation of infrequent situations.", "population_specificity": "Patients undergoing bariatric surgery in the USA.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:26.783316+00:00"}
{"study_id": 114874, "supplement_id": 913, "safety_score": "75", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the safety, feasibility, and outcomes of bariatric surgery (BS) in kidney (KT) and liver transplantation (LT) patients.", "results_summary": "BS was found to be safe and feasible in end-stage renal disease (ESRD) and KT patients, with slightly higher complication rates than the non-transplant population but comparable weight loss and comorbidity improvement. Sleeve gastrectomy (SG) was preferred before KT, while both SG and gastric bypass (GB) showed comparable results post-KT; BS before LT had high complication rates, especially after GB, but SG post-LT yielded the best outcomes.", "population_specificity": "Patients with end-stage renal disease (ESRD), kidney transplant (KT) recipients, and liver transplantation (LT) candidates or recipients.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "Immunosuppression (IS) changes after BS were rare.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:29.502453+00:00"}
{"study_id": 114876, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness of oral iron supplementation using non-heme versus heme iron for treating iron deficiency in women who had undergone Roux-en-Y gastric bypass surgery.", "results_summary": "The study found that oral supplementation with FeSO (non-heme iron) was effective in treating iron deficiency in post-RYGB patients, though specific comparative results between non-heme and heme iron were not fully detailed in the abstract.", "population_specificity": "Women post-Roux-en-Y gastric bypass surgery with iron deficiency.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:30.192800+00:00"}
{"study_id": 114877, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of gut microbiota in estrogen-modulated diseases and evaluate therapeutic interventions like bariatric surgery for their potential to modulate the microbiome and metabolic profile.", "results_summary": "The study suggests that bariatric surgery, by altering the gut microbiome, can impact estrogen levels and alleviate estrogen-modulated disease states such as obesity, metabolic syndrome, and cognitive function. It highlights the bidirectional relationship between gut microbiota and metabolic profiles in estrogen-driven diseases.", "population_specificity": "Post-menopausal women and individuals with estrogen-modulated diseases (e.g., obesity, metabolic syndrome, cancer).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:32.108926+00:00"}
{"study_id": 114879, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the diagnostic accuracy and reproducibility of a visual liver score for stratifying NAFLD/NASH risk in obese patients undergoing bariatric surgery and determining the need for liver biopsy.", "results_summary": "The study found that a simple intraoperative visual liver score was useful and reliable for NAFLD risk stratification, with normal liver appearance reliably excluding significant liver disease and reducing unnecessary biopsies.", "population_specificity": "Obese adults (BMI 45 \u00b1 8.3 kg/m\u00b2, age 44.6 \u00b1 12 years) undergoing bariatric surgery.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:32.175375+00:00"}
{"study_id": 114878, "supplement_id": 913, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "To evaluate the efficacy, pharmacokinetic profile, and tolerability of subcutaneous exendin 9-39 injection in patients with post-bariatric hypoglycaemia.", "results_summary": "All doses of subcutaneous exendin 9-39 effectively prevented hyperinsulinaemic hypoglycaemia, improved symptoms, and were well tolerated with no adverse events. The postprandial glucose nadir increased by 66%, peak insulin reduced by 57%, and neuroglycopenic symptoms reduced by 80%.", "population_specificity": "Nine women with recurrent symptomatic hypoglycaemia after Roux-en-Y gastric bypass.", "effective_dosage": "Single ascending doses (specific amounts not detailed).", "study_duration": "Single-dose administration.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:32.574754+00:00"}
{"study_id": 114871, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of bariatric surgery in treating severe obesity and type 2 diabetes mellitus (T2DM), including its metabolic benefits and long-term outcomes.", "results_summary": "Bariatric surgery showed significant weight loss, T2DM remission, and improved cardiometabolic risk factors in the short and medium term. Long-term benefits included durable weight loss, prevention of T2DM and cancer, improved glycemic control, and reduced mortality.", "population_specificity": "Patients with severe obesity (class III) or class II obesity with inadequately controlled T2DM, and class I obesity with uncontrolled hyperglycemia.", "effective_dosage": "Not specified", "study_duration": "Short, medium, and long-term follow-up (specific duration not provided)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:32.789477+00:00"}
{"study_id": 114880, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess bariatric surgeons' knowledge and adherence to the ACERTO Project recommendations and compare their assumptions with actual perioperative care practices.", "results_summary": "Most surgeons (72%) reported following the ACERTO protocol thoroughly, with good alignment in practices like early postoperative feeding, antibiotic prophylaxis, and analgesia. However, preoperative fasting times were significantly longer than reported by surgeons.", "population_specificity": "Patients undergoing gastroplasty for morbid obesity (200 records analyzed).", "effective_dosage": "Not applicable", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:34.000163+00:00"}
{"study_id": 114881, "supplement_id": 913, "safety_score": "70", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to review the causes, diagnosis, and treatment of chronic diarrhea after bariatric surgery, focusing on its impact on quality of life and nutrient deficiencies.", "results_summary": "The study found that diarrhea is common after bariatric procedures with malabsorptive elements, complicating diagnosis due to anatomical changes and limited testing accuracy. It highlighted the role of gut microbiota and bile acids in diarrhea and emphasized the need for better diagnostic and treatment approaches.", "population_specificity": "Patients who underwent bariatric surgery, particularly those with malabsorptive procedures like Roux-Y Gastric Bypass and Biliopancreatic Diversion.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:36.095420+00:00"}
{"study_id": 114883, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate bile acid profiles up to 5 years after Roux-en-Y gastric bypass and biliopancreatic diversion with duodenal switch and explore their relationship with weight loss, lipid profile, and glucose metabolism.", "results_summary": "Total bile acid concentrations increased significantly over 5 years after both surgeries, with greater increases in total and primary bile acids after duodenal switch. Higher bile acid levels were associated with lower BMI, greater weight loss, and reduced total cholesterol.", "population_specificity": "60 patients with BMI 50-60 kg/m\u00b2 from two Scandinavian University Hospitals.", "effective_dosage": "Not specified", "study_duration": "5 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:38.946400+00:00"}
{"study_id": 114884, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the impact of mandated preoperative weight loss regimens on bariatric surgery outcomes, including weight loss and postoperative complications.", "results_summary": "The study found no sufficient evidence linking mandatory preoperative weight loss regimens to achieved weight loss or durable bariatric outcomes. Preoperative weight loss may reduce postoperative complications, but this finding is inconsistent and requires further validation.", "population_specificity": "Patients undergoing bariatric surgery with mandated preoperative weight loss regimens.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:39.853838+00:00"}
{"study_id": 114885, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the effectiveness and multidisciplinary approach of bariatric surgery for severely obese children and adolescents across all age groups.", "results_summary": "The study found that lifestyle interventions are generally ineffective for severely obese pediatric patients, while bariatric surgery, offered in a multidisciplinary setting, presents a viable alternative. The paper highlights the unique approach of their center in providing this surgery across all pediatric age groups.", "population_specificity": "Severely obese children and adolescents (BMI > 99th percentile for age and gender).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:40.518312+00:00"}
{"study_id": 114886, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the role of bariatric surgery as a therapeutic strategy for non-alcoholic fatty liver disease (NAFLD) in the context of obesity and metabolic syndrome.", "results_summary": "The study highlights that bariatric surgery is one of the few available therapeutic strategies for NAFLD, focusing on weight loss, but notes the lack of approved pharmacological treatments. Non-invasive diagnostic methods have simplified patient management, though histological diagnosis remains principal.", "population_specificity": "Patients with NAFLD, particularly those with obesity, diabetes, or metabolic syndrome.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:40.934211+00:00"}
{"study_id": 114887, "supplement_id": 913, "safety_score": "70", "efficacy_score": 86, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of endoscopic closure versus internal drainage for managing fistulas after sleeve gastrectomy.", "results_summary": "Endoscopic treatment was successful in 86% of cases, with internal drainage showing significantly higher primary success (86%) compared to closure management (63%). Factors like large collections (>5 cm) and surgical reintervention before endoscopy negatively impacted outcomes.", "population_specificity": "100 patients (78 women, mean age 42 \u00b1 12 years) treated for fistulas after sleeve gastrectomy in a referral center.", "effective_dosage": "Not Assessed", "study_duration": "Mean follow-up of 6 \u00b1 27 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:41.624673+00:00"}
{"study_id": 114882, "supplement_id": 913, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the effects of goal-directed fluid therapy (GDFT) via Pleth Variability Index (PVI) on fluid management in morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass (RYGB) surgery.", "results_summary": "The PVI group required significantly less intraoperative fluid than the control group, with no significant differences in lactate or creatinine levels before or after surgery. The study concluded that dynamic indicators like PVI help reduce fluid volume without affecting patient outcomes.", "population_specificity": "Morbidly obese patients undergoing elective laparoscopic RYGB surgery.", "effective_dosage": "Control group: 500 ml crystalloid bolus followed by 4-8 ml/kg/h infusion. PVI group: 500 ml crystalloid bolus followed by 2 ml/kg/h infusion, with 250 ml colloid if PVI > 14%.", "study_duration": "Intraoperative period (specific duration not stated).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:41.879306+00:00"}
{"study_id": 114888, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the role of gut microbiota modulation, including bariatric surgery, as a strategy to treat obesity.", "results_summary": "The study noted that bariatric surgery, among other methods, can positively modulate gut microbiota to treat obesity, but effectiveness may vary due to unrelated factors like genetics, age, or lifestyle. Some cases showed invalid or contrary effects.", "population_specificity": "Not specified (general obesity population implied).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:42.201829+00:00"}
{"study_id": 114889, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to provide an overview of the literature on the effects of bariatric surgery on energy homeostasis, including its mechanisms and outcomes.", "results_summary": "Bariatric surgery effectively reduces energy intake and body fat by restricting stomach size and causing malabsorption, while also influencing appetite regulation, gut hormones, bile acids, and microbiota. It may also increase energy expenditure, contributing to improved energy balance.", "population_specificity": "Individuals with severe obesity and type 2 diabetes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:45.014685+00:00"}
{"study_id": 114890, "supplement_id": 913, "safety_score": "70", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to review the indications, postoperative management, and long-term outcomes of bariatric surgery for managing type 2 diabetes in severely obese patients.", "results_summary": "The study found that bariatric surgery is superior to medical therapy for managing type 2 diabetes in severely obese patients, with remission rates varying between 20% and 90% depending on the type of surgery. The mechanisms include caloric restriction, hormonal changes, and alterations in microbiota and incretins.", "population_specificity": "Severely obese patients with type 2 diabetes.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:47.087409+00:00"}
{"study_id": 114891, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of bariatric surgery as a therapy for obesity and type 2 diabetes, comparing it to pharmacological treatments and exploring novel peptide-based approaches.", "results_summary": "The study found that bariatric surgery is currently the most effective therapy for substantial weight loss in obesity, while pharmacological treatments have limited success and notable adverse effects. Novel multifunctional peptides, particularly dual agonists targeting glucagon and GLP-1 receptors, show promise as future treatments.", "population_specificity": "Individuals with obesity and type 2 diabetes (general discussion, no specific cohort mentioned).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:48.314512+00:00"}
{"study_id": 114893, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 68, "study_goal": "The researchers aimed to compare the annual costs of clinical and surgical treatment for severe obesity from the perspective of the Brazilian Public Health System.", "results_summary": "The surgical group had higher costs in the first postoperative year compared to the clinical group, but costs decreased progressively from the second year onward. Indirect costs also decreased significantly after surgery.", "population_specificity": "274 patients (140 in the surgical group, 134 in the clinical group) from three reference centers in Brazil.", "effective_dosage": "Not specified", "study_duration": "Follow-up periods included up to 1 year, 1-2 years, 2-3 years, and >3 years post-surgery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:49.610470+00:00"}
{"study_id": 114895, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential role of bariatric surgery in managing NAFLD, focusing on its benefits in improving steatosis, inflammation, and fibrosis.", "results_summary": "The study found that bariatric surgery shows promise in improving NAFLD outcomes, including reductions in steatosis, inflammation, and fibrosis over follow-up periods, with potential to halt or reverse disease progression.", "population_specificity": "Morbidly obese patients with NAFLD.", "effective_dosage": "Not specified", "study_duration": "Duration of follow-up not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:50.475065+00:00"}
{"study_id": 114894, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential of bariatric surgery to improve cardiac structure and function in severely obese patients with heart failure (HFpEF and HFrEF).", "results_summary": "Observational studies suggest bariatric surgery is associated with improved cardiac structure/function in severely obese patients with HF, including those with preserved or reduced ejection fraction, and may serve as a rescue treatment or bridge to heart transplantation.", "population_specificity": "Severely obese adults with heart failure (HFpEF and HFrEF).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:50.791642+00:00"}
{"study_id": 114896, "supplement_id": 913, "safety_score": "75", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the metabolic benefits of bariatric surgery, particularly its effectiveness in treating type 2 diabetes and related conditions compared to lifestyle or medical management.", "results_summary": "The study found that metabolic surgery is more effective than lifestyle or medical management in achieving glycemic control, sustained weight loss, and reducing diabetes comorbidities, with perioperative adverse events similar to other gastrointestinal surgeries. New guidelines now support its use in patients with lower body mass index.", "population_specificity": "Patients with severe obesity and type 2 diabetes, with expanded guidelines now including those with lower body mass index.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:50.898273+00:00"}
{"study_id": 114892, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 65, "study_goal": "The researchers aimed to compare the cost and healthcare utilization of patients with obesity and type 2 diabetes mellitus (T2DM) randomized into either Roux-en-Y gastric bypass (RYGB) surgery or an intensive lifestyle and medical intervention (ILMI).", "results_summary": "The study found no significant cost savings for RYGB compared to ILMI over two years. Pharmacy costs were lower for RYGB patients in year 2, but inpatient and emergency room costs were higher for surgery patients. Nonrandomized patients had higher median total costs than randomized patients.", "population_specificity": "Adult patients with obesity and T2DM recruited from Kaiser Permanente Washington between 2011 and 2012.", "effective_dosage": "Not specified", "study_duration": "2 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:50.965622+00:00"}
{"study_id": 114897, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the efficacy and safety of intragastric balloon (IGB) devices with bariatric surgery and pharmacotherapy for obesity treatment.", "results_summary": "The study found that IGBs had a pooled weighted-mean %TBWL of 9.7% at 6 months, which was statistically greater than controls but lower than bariatric surgery (27% for RYGB) and less effective than the most efficacious weight loss drug, Qsymia. Serious adverse events occurred in 10.5% of IGB cases, with a pooled reported incidence of 28.2% for adverse events.", "population_specificity": "Individuals with obesity (specific demographics not detailed).", "effective_dosage": "Not specified (IGBs placed endoscopically for up to 6 months).", "study_duration": "6 months (for most studies).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:55.885889+00:00"}
{"study_id": 114898, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review changes in food preferences after Roux-en-Y gastric bypass (RYGB) and explore underlying mechanisms in both humans and animals.", "results_summary": "The study found that RYGB leads to a shift away from calorie-dense sweet and high-fat foods in both humans and animals, though methodological differences may cause inconsistencies in findings. Future human studies should focus on direct measures to align with animal study insights.", "population_specificity": "Humans and experimental animals post-RYGB.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:56.268332+00:00"}
{"study_id": 114899, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to examine the efficacy and safety of gastrointestinal medical devices, including bariatric surgery, as treatments for obesity, comparing them to lifestyle interventions and pharmacotherapy.", "results_summary": "The study found that bariatric surgery provides substantial and durable weight loss but noted that limited access, perceived risks, and costs restrict its uptake. Medical devices were highlighted as a potential middle-ground option between conservative treatments and surgery.", "population_specificity": "Individuals with obesity (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:57.185424+00:00"}
{"study_id": 114900, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the effect of obesity and weight loss, particularly after bariatric surgery, on health-related quality of life (HRQoL).", "results_summary": "Obesity was associated with significantly lower HRQoL, and bariatric surgery consistently demonstrated improved HRQoL, likely due to greater weight loss compared to other treatments. Non-surgical weight loss also showed HRQoL improvements, but results were inconsistent across studies.", "population_specificity": "Individuals with obesity undergoing various weight-loss interventions, including bariatric surgery.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:57.696110+00:00"}
{"study_id": 114901, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine if preoperative C-peptide and islet cell antibody testing could improve the classification of type 1 versus type 2 diabetes in bariatric surgery patients compared to clinical assessment alone.", "results_summary": "Clinical characteristics failed to correctly identify type 1 diabetes, but C-peptide testing showed potential for improving diabetes classification. Three participants, including the one with type 1 diabetes, tested positive for islet cell antibodies.", "population_specificity": "Adults with clinically diagnosed type 2 diabetes and BMI 30-40 kg/m\u00b2 undergoing bariatric surgery.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:58.730559+00:00"}
{"study_id": 114903, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of weight reduction through bariatric surgery (VSG) versus behavioral therapy on migraine severity in obese women.", "results_summary": "Bariatric surgery (VSG) led to significant reductions in migraine severity and duration, as well as increased migraine-free days, even before substantial weight loss. Behavioral therapy showed some improvement but was less effective than surgery.", "population_specificity": "Obese women aged 18-60 years with migraine headache.", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:58.837380+00:00"}
{"study_id": 114904, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review recent developments and clinical outcomes of endoscopic bariatric and metabolic procedures, focusing on their role between lifestyle counseling and bariatric surgery.", "results_summary": "The study found that FDA-approved endoscopic therapies are now available for patients with high BMI (up to 55 kg/m\u00b2), showing metabolic improvements and weight loss outcomes, but optimal results require combining these therapies with diet and lifestyle interventions for at least 12 months.", "population_specificity": "Patients with obesity, particularly those with BMI up to 55 kg/m\u00b2 who may not qualify for or want bariatric surgery.", "effective_dosage": "Not specified", "study_duration": "Minimum of 12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:01:59.813139+00:00"}
{"study_id": 114902, "supplement_id": 913, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the long-term outcomes of bariatric surgery, including weight loss, morbidity, comorbidity changes, and quality of life over a 10-year period.", "results_summary": "Gastric bypass resulted in greater long-term weight loss (-42.4 kg vs. -27.4 kg for gastric banding) and lower reoperation rates (8.1% vs. 31.4%). Significant improvements in diabetes (68%), hypertension (61%), and dyslipidemia (57%) were observed, with sustained quality-of-life benefits.", "population_specificity": "250 patients with a BMI of 35-60 kg/m\u00b2, randomized to laparoscopic gastric bypass (111) or gastric banding (86).", "effective_dosage": "Not Assessed", "study_duration": "10-year follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:00.321044+00:00"}
{"study_id": 114907, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the safety and efficacy of bariatric surgery as an adjuvant therapy for obesity management in Australia.", "results_summary": "The abstract does not provide specific findings on bariatric surgery, only stating that it will be evaluated alongside other therapies.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:03.547413+00:00"}
{"study_id": 114905, "supplement_id": 913, "safety_score": "70", "efficacy_score": 95, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the role of bariatric surgery, specifically vertical sleeve gastrectomy (VSG) and Roux-en-Y gastric bypass (RYGB), as a treatment for type 2 diabetes (T2D) in adolescents.", "results_summary": "Bariatric surgery significantly improved glycemic control, with T2D remission observed in 95-100% of adolescents. The surgery also potentially improved T2D-related comorbidities, though risks like nutritional deficiencies were noted.", "population_specificity": "Obese adolescents with type 2 diabetes.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:03.778197+00:00"}
{"study_id": 114906, "supplement_id": 913, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the clinical outcomes and intraoperative parameters of one-anastomosis gastric bypass (OAGB) and laparoscopic sleeve gastrectomy (LSG) in obese patients.", "results_summary": "The study found that OAGB resulted in increased weight loss, higher remission of comorbidities, shorter hospital stays, and lower mortality compared to LSG, with similar rates of leaks and intra-abdominal bleeding between the two methods.", "population_specificity": "Obese patients (6761 total across 17 studies).", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:04.369648+00:00"}
{"study_id": 114910, "supplement_id": 913, "safety_score": "60", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to review current obesity treatments, including bariatric surgery, and explore newer endoscopic and pharmacotherapy options for weight loss.", "results_summary": "Bariatric surgery is effective for obesity but carries severe short- and long-term complications. Newer minimally invasive techniques and pharmacotherapies are being developed to bridge the gap between lifestyle modifications and surgery.", "population_specificity": "Individuals classified as obese (BMI \u226530).", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:06.154011+00:00"}
{"study_id": 114908, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to determine whether mesenteric defect closure during laparoscopic gastric bypass surgery affects health-related quality-of-life (HRQoL) post-surgery.", "results_summary": "The study found that mesenteric defect closure was associated with slightly higher ratings in social functioning and role emotional but no clinically relevant difference in HRQoL overall. No difference was observed on the obesity problems (OP) scale between the groups.", "population_specificity": "Patients undergoing laparoscopic gastric bypass surgery at 12 bariatric surgery centers (n=2507).", "effective_dosage": "Not applicable (surgical intervention).", "study_duration": "Follow-up at 1 and 2 years post-operation.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:06.494413+00:00"}
{"study_id": 114911, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "To establish consensus-based guidelines for the perioperative management of obstructive sleep apnea (OSA) in patients undergoing metabolic and bariatric surgery (MBS).", "results_summary": "The study provided 58 statements and recommendations, including polysomnography as the gold standard for OSA diagnosis, continuous positive airway pressure for moderate/severe OSA, and minimizing perioperative sedatives/opioids. Consensus (>70%) was reached for 55 recommendations.", "population_specificity": "Patients with OSA undergoing metabolic and bariatric surgery.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:06.521950+00:00"}
{"study_id": 114913, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of bariatric surgery and explore alternative neuromodulatory approaches for treating severe obesity, particularly in cases where traditional methods fail.", "results_summary": "The study found that while bariatric surgery is frequently performed for severe obesity, 40% of patients experience long-term weight regain or metabolic syndrome. Non-invasive neuromodulatory techniques like TMS and tDCS require further investigation, while deep brain stimulation shows promise for treatment-resistant obesity.", "population_specificity": "Individuals with severe obesity, particularly those who are treatment-resistant.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:08.812699+00:00"}
{"study_id": 114912, "supplement_id": 913, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety and long-term efficacy of endoscopic transoral outlet reduction (TORe) using an endolumenal suturing device for managing weight regain after Roux-en-Y gastric bypass surgery (RYGB).", "results_summary": "The study found that TORe resulted in significant weight loss at 6, 12, and 18 months post-procedure, with no serious adverse events reported. The meta-analysis confirmed these findings, showing a pooled weight loss of 8.4 kg at 12 months with low heterogeneity across studies.", "population_specificity": "Patients who had undergone RYGB and experienced weight regain (mean age 47, mean BMI 36.8).", "effective_dosage": "Not specified", "study_duration": "Follow-up at 6, 12, and 18 months post-intervention.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:09.136657+00:00"}
{"study_id": 114914, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to assess the congruence between patients' perceived and calculated weight status classifications (WSC) and examine differences based on surgical status, gender, and age groups.", "results_summary": "Presurgery patients and emerging/early adulthood patients showed greater congruence in their WSC perceptions compared to postsurgery and middle/late adulthood patients. No gender differences were found overall, but presurgery females were more congruent than postsurgery females, while males showed no difference.", "population_specificity": "Patients undergoing or having undergone bariatric surgery at a university hospital.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:11.804676+00:00"}
{"study_id": 114915, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to summarize literature on weight management in type 1 diabetes (T1D), focusing on barriers, T1D-specific factors impacting weight loss, and interventions.", "results_summary": "The study found that weight gain is linked to intensive insulin therapy, overweight/obesity prevalence in T1D is rising, and multiple factors (demographic, clinical, environmental, psychosocial) contribute to weight issues. Fear of hypoglycemia hinders physical activity, and evidence-based weight management guidelines for T1D are urgently needed.", "population_specificity": "Individuals with type 1 diabetes (youth and adults).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:13.049690+00:00"}
{"study_id": 114916, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to compare the clinical conditions of obese patients before and after bariatric surgery, focusing on anthropometric, metabolic, biochemical, and clinical parameters.", "results_summary": "The study found significant weight and lipid profile reductions in both genders six months post-surgery, with notable improvements in biochemical, anthropometric, metabolic, and clinical parameters\u2014particularly in female subjects\u2014including reduced obesity-related morbidities (e.g., hypertension, diabetes) and decreased medication use.", "population_specificity": "134 obese patients (91.8% female, 35% aged 18\u201329, 60.4% with grade III obesity) who underwent bariatric surgery between 2009\u20132014.", "effective_dosage": "Not specified", "study_duration": "6 months pre- and post-surgery", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:14.365003+00:00"}
{"study_id": 114918, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the endocrine changes after RYGB and VSG and explore their mechanistic role in the metabolic success of bariatric surgery.", "results_summary": "The study found that RYGB and VSG are highly effective for sustained weight loss and T2DM remission, with similar success despite different anatomical rearrangements. Both surgeries cause significant endocrine changes, particularly within the intestine, which are implicated in metabolic improvements, though causation remains unclear.", "population_specificity": "Not specified (general obesity and T2DM population implied)", "effective_dosage": "Not mentioned", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:14.368869+00:00"}
{"study_id": 114920, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 65, "study_goal": "To determine the efficacy of intraoperative leak test (IOLT) in sleeve gastrectomy and compare routine versus selective use.", "results_summary": "Routine IOLT had very poor sensitivity (8.7%) and did not reduce postoperative leak rates; 91% of patients who developed leaks had negative IOLT results. No significant difference in leak rates was found between routine and selective IOLT use.", "population_specificity": "4,284 patients undergoing sleeve gastrectomy across eight teaching hospitals (private, university, and military facilities).", "effective_dosage": "Not applicable", "study_duration": "5-year retrospective analysis (2010-2014)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:15.225306+00:00"}
{"study_id": 114917, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether revisional bariatric surgery could improve metabolic diseases, particularly diabetes, in patients who did not achieve remission after initial bariatric surgery.", "results_summary": "Revisional bariatric surgery led to additional weight loss (20-80% excess weight loss or BMI reduction of 10-30%) and improved diabetes in 65-100% of patients, with varying success rates depending on the type of initial and revisional procedure. Conversion to RYGB showed the highest improvement rates (62-79%), while other revisions like AGB to SG or SG to duodenal switch also demonstrated significant benefits.", "population_specificity": "Patients with residual or recurrent metabolic diseases (e.g., diabetes) after primary bariatric surgery.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:15.662667+00:00"}
{"study_id": 114921, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the selection, management, and outcomes of adolescents undergoing weight loss surgery (WLS) to assess its viability as a treatment for severe obesity in this population.", "results_summary": "Medium-term to long-term outcomes of WLS in adolescents are similar to those in adults, with effectiveness dependent on multidisciplinary team management and family support. Future research is needed to optimize surgical indications, postoperative care adherence, and long-term impacts on life expectancy.", "population_specificity": "Adolescents with severe obesity and associated cardiometabolic risks.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:16.365507+00:00"}
{"study_id": 114922, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate changes in dietary intake and eating behavior among adolescents with obesity who underwent bariatric surgery compared to those who received lifestyle modification.", "results_summary": "Adolescents who underwent bariatric surgery experienced significantly greater weight loss and reductions in disordered eating symptoms compared to those who received lifestyle modification, though total caloric intake did not differ between groups.", "population_specificity": "Adolescents (n=288; 219 female, 69 male) with severe obesity.", "effective_dosage": "Not specified", "study_duration": "6, 12, and 24 months (surgery patients only)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:17.117967+00:00"}
{"study_id": 114923, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the literature on endoscopic approaches, including bariatric surgery, as alternatives for weight loss and discuss their clinical considerations.", "results_summary": "The abstract highlights that bariatric surgery is a traditional obesity treatment, while newer endoscopic approaches like intragastric balloons have shown promise despite initial complications. Improved devices have been approved, and other endoscopic methods are under evaluation.", "population_specificity": "Individuals with medically complicated obesity.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:19.861622+00:00"}
{"study_id": 114924, "supplement_id": 913, "safety_score": "70", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to describe common bariatric surgical procedures, their postoperative appearances, and intrathoracic complications.", "results_summary": "The study highlights that bariatric surgery is the most reliable long-term solution for obesity, though thoracic complications, while rare, can lead to severe morbidity and mortality. It emphasizes the importance of prompt recognition of complications to optimize patient outcomes.", "population_specificity": "Patients undergoing bariatric surgery (specific demographics not detailed).", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:20.738533+00:00"}
{"study_id": 114925, "supplement_id": 913, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to compare the safety and aesthetic outcomes of the three-trocar sleeve gastrectomy technique versus the five-trocar technique in bariatric surgery.", "results_summary": "The study found no significant difference in early post-operative complications between the two techniques, but the three-trocar group had better patient satisfaction with aesthetic results despite a modest increase in operative time.", "population_specificity": "90 patients with morbid obesity evaluated by a multidisciplinary team.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:21.633941+00:00"}
{"study_id": 114926, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to explore the role of bariatric surgery as an important treatment option for obesity, alongside other interventions like diet and lifestyle changes.", "results_summary": "The abstract highlights bariatric surgery as an emerging important treatment for obesity, but does not provide specific results on its efficacy or outcomes compared to other treatments. It emphasizes the complexity of obesity and the need for a multifaceted approach.", "population_specificity": "Individuals with obesity, including those with comorbidities and varying socioeconomic and environmental backgrounds.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:22.970283+00:00"}
{"study_id": 114927, "supplement_id": 913, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to establish a differential diagnosis and determine clinical associations and outcomes for almost-normal liver biopsies, excluding biopsies obtained during bariatric surgery.", "results_summary": "The study did not evaluate the effects of bariatric surgery; it focused on almost-normal liver biopsies and their clinical associations, excluding bariatric surgery cases.", "population_specificity": "Patients with histologically almost-normal liver biopsies from two institutions, excluding those with biopsies obtained during bariatric surgery.", "effective_dosage": "Not available", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:23.137618+00:00"}
{"study_id": 114929, "supplement_id": 913, "safety_score": "80", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy and side effects of bariatric surgery versus advanced medical treatments (GLP-1 analogues and SGLT2 inhibitors) for managing type 2 diabetes in class I obese patients.", "results_summary": "Bariatric surgery significantly lowered HbA1c and fasting plasma glucose (FPG) after 12 months, with clinically meaningful improvements in lipid profile compared to medical treatments, which showed clinically insignificant changes. The study concluded that bariatric surgery is superior to medical therapies for treating T2DM in this population.", "population_specificity": "Class I obese patients (BMI 30\u201335 kg/m\u00b2) with type 2 diabetes mellitus (T2DM) in India.", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:25.070258+00:00"}
{"study_id": 114928, "supplement_id": 913, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the prevalence and mortality rate of portomesenteric vein thrombosis (PMVT) as a complication of laparoscopic sleeve gastrectomy (LSG) and evaluate the effectiveness of antithrombotic prophylaxis.", "results_summary": "The study found PMVT to be an infrequent but not rare complication after LSG, with a prevalence of 0.52% and a mortality rate of 1.61%. Short-course antithrombotic prophylaxis (<10 days) was associated with increased risk, and extended prophylaxis (4 weeks) was recommended.", "population_specificity": "Patients who underwent LSG for morbid obesity from January 2011 to December 2016.", "effective_dosage": "Sodium enoxaparin 40 mg sc once daily for 4 weeks (or twice daily for high-risk patients).", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:25.131830+00:00"}
{"study_id": 50226, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not specify the study's goal regarding Beta-glucans.", "results_summary": "The abstract does not provide results specific to Beta-glucans.", "population_specificity": "Not specified.", "effective_dosage": "Not available.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:31.025456+00:00"}
{"study_id": 50219, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to provide a comprehensive review of \u03b2-glucan's structure, sources, health benefits, extraction methods, and global trade dynamics.", "results_summary": "The study found that \u03b2-glucan has biofunctional roles in immune modulation, cholesterol regulation, and gastrointestinal health, supported by clinical studies. It also highlighted its diverse applications in food, pharmaceuticals, and cosmetics.", "population_specificity": "Not specified (general human consumption)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:32.806590+00:00"}
{"study_id": 50221, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential beneficial effects of beta-glucans, among other dietary supplements, on COVID-19 infection risk and symptom severity.", "results_summary": "The study suggests that beta-glucans, along with other micronutrients and supplements, may support immune system function, potentially benefiting individuals before and during SARS-CoV-2 infection. However, additional studies are needed to confirm these effects.", "population_specificity": "General population in the context of COVID-19 infection risk and immune support.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:32.935454+00:00"}
{"study_id": 50223, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the background, characterization, extraction methods, and membrane-based purification techniques of \u03b2-glucans, focusing on their therapeutic benefits and structural properties.", "results_summary": "The study highlighted \u03b2-glucans' potential therapeutic benefits, including cholesterol management, diabetes treatment, cardiovascular disease prevention, tumor growth inhibition, and anti-inflammatory effects, linked to their molecular weight, structure, and branching. It also discussed extraction and purification methods, particularly membrane-based techniques, for obtaining pure or crude \u03b2-glucan.", "population_specificity": "Not specified (general human health context)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:33.520671+00:00"}
{"study_id": 50220, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the biological properties, structure-function relationships, and mechanisms of mushroom polysaccharides, including Beta-glucans, with a focus on their prebiotic potential and other health benefits.", "results_summary": "The study found that Beta-glucans and other mushroom polysaccharides exhibit diverse bioactivities, including immunomodulatory, anti-inflammatory, antimicrobial, and gut microbiota modulation effects. Prebiotic potential was linked to impacts on intestinal barriers and microbiota dysbiosis, with animal studies suggesting cytokine reduction and redox balance restoration.", "population_specificity": "Not specified (review of existing literature).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:33.876371+00:00"}
{"study_id": 50218, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether a multicomponent nasal spray containing carboxymethyl-beta-glucan, among other ingredients, could reduce respiratory infections and wheezing episodes in preschoolers.", "results_summary": "The study found that preschoolers treated with the multicomponent nasal spray experienced fewer respiratory infections and used fewer beta-2 agonists compared to those on standard therapy alone. The results were statistically significant (P = 0.01 and 0.029, respectively).", "population_specificity": "Preschoolers with frequent respiratory infections and associated wheezing.", "effective_dosage": "Two sprays per nostril twice daily (specific beta-glucan dosage not detailed).", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:34.080943+00:00"}
{"study_id": 50217, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the effects of nutraceutical formulations containing Beta-glucans, among other components, on gut microbiota modulation and improvements in metabolic, inflammatory, and quality-of-life parameters in overweight/obese individuals.", "results_summary": "The study found that Beta-glucans, as part of the nutraceutical blends, contributed to gut microbiota reshaping, improved sleep patterns, quality-of-life perception, cytokine expression, and anthropometric parameters, with the NSupple_Silybum group showing particularly positive modulation of Bacteroidetes and related genera.", "population_specificity": "Overweight/obese volunteers from Brazil's southeastern region.", "effective_dosage": "Not specified", "study_duration": "180 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:34.126523+00:00"}
{"study_id": 50224, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine if beta-glucan supplementation could alleviate fatigue, unrefreshing sleep, anxiety/depression symptoms, and improve health-related quality of life in ME/CFS patients.", "results_summary": "Beta-glucan supplementation significantly improved cognitive fatigue (measured by FIS-40 scores) after 36 weeks compared to baseline. The study did not report on other outcomes like sleep, anxiety/depression, or quality of life.", "population_specificity": "65 ME/CFS patients", "effective_dosage": "250 mg beta-glucan, 3.75 \u00b5g vitamin D3, 1.05 mg vitamin B6, and 7.5 mg zinc per capsule, taken as four capsules once daily", "study_duration": "36 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:34.389988+00:00"}
{"study_id": 50227, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize the current methods for obtaining mushroom polysaccharides (especially \u03b2-glucans), their structural characteristics, and their roles in immune-enhancing and antitumor activities.", "results_summary": "The study highlights that \u03b2-glucans exhibit significant immune-enhancing and antitumor activities, which are influenced by their structural features. It also discusses methods for preparing polysaccharide derivatives and their potential clinical applications.", "population_specificity": "Not specified (general review of existing research)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:38.290450+00:00"}
{"study_id": 50230, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the sources of \u03b2-glucans, their cultivation conditions for sustainable production, and their immune-modulatory potential.", "results_summary": "The study highlights that \u03b2-glucans from various sources (cereals, mushrooms, microalgae, bacteria, and seaweeds) have clinical potential for diseases like cancer and cardiovascular conditions, with cultivation conditions influencing their production. It also discusses their immune-modulatory effects.", "population_specificity": "Not specified (review article)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:40.596257+00:00"}
{"study_id": 50228, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to examine the effects of long-term consumption of oat beta-glucans (BGs) on lipid and glucose metabolism biomarkers in overweight/obese subjects.", "results_summary": "The study found that beta-glucans had some effects on lipid metabolism, specifically on VLDL-C levels, but detailed results for other biomarkers were not fully reported in the abstract.", "population_specificity": "Overweight/obese subjects maintaining their dietary habits and physical activity.", "effective_dosage": "2.5 g twice a day.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:40.883907+00:00"}
{"study_id": 50232, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the effects of Beta-glucans on gut microbiota, including their metabolism, impact on microbial populations, gut infections, prebiotic effects, and fermentation properties.", "results_summary": "The study found that Beta-glucans modulate gut microbiota, enhance intestinal fermentation, produce beneficial metabolites, and exhibit prebiotic effects, suggesting therapeutic potential for gut health.", "population_specificity": "Not specified (general human gut microbiota)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:41.026407+00:00"}
{"study_id": 50231, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the composition and medicinal benefits of water-insoluble cell walls from Fomes fomentarius, focusing on \u03b2-glucans and their potential therapeutic effects.", "results_summary": "The study found that F. fomentarius fibers, rich in \u03b2-glucans, exhibit immune modulation, wound healing, heavy metal absorption, and antimicrobial properties, with broad applications in treating chronic and multifactorial diseases.", "population_specificity": "Not specified (in vitro, in vivo, ex vivo, and clinical studies referenced).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:41.360118+00:00"}
{"study_id": 50235, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review the effects of Beta-glucans on obesity and obesity-related issues, including mechanisms of action, clinical trial results, and possible side effects.", "results_summary": "The abstract does not provide specific findings about Beta-glucans, only mentioning it as one of several ingredients reviewed for weight loss and obesity treatment.", "population_specificity": "Not specified", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:41.412084+00:00"}
{"study_id": 50233, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 73, "quality_score": 85, "study_goal": "The researchers aimed to rank the efficacy of various soluble dietary fibers, including Beta-glucans, in improving glycemic and lipid levels in patients with type 2 diabetes.", "results_summary": "Beta-glucans were found to be the most effective intervention for reducing fasting insulin levels and HOMA-IR (SUCRA: 73.45%), but were not the top performer for other glycemic or lipid outcomes.", "population_specificity": "Adult patients with type 2 diabetes mellitus.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:42.086336+00:00"}
{"study_id": 50234, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of dietary polysaccharides, including Beta-glucans, in influencing colorectal cancer mechanisms and intestinal health.", "results_summary": "The study suggests that dietary polysaccharides like Beta-glucans may help lower colorectal cancer incidence by modulating microbial diversity, producing short-chain fatty acids, controlling inflammatory profiles, and regulating tumoral pathways. However, specific efficacy data on Beta-glucans alone are not detailed.", "population_specificity": "General discussion on colorectal cancer mechanisms, not specific to a studied population.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:42.624393+00:00"}
{"study_id": 50236, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to test the potential of microalgae (including Beta-glucans) as anti-inflammatory and anti-oxidative agents for healthy aging.", "results_summary": "The abstract does not provide specific results regarding Beta-glucans's effects.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:45.135873+00:00"}
{"study_id": 50237, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of a brewer's spent grain (BSG) extract supplement, containing \u03b2-glucans, in reducing postprandial glycemia and insulinemia in normoglycemic subjects.", "results_summary": "The study found that BSG extract, which includes \u03b2-glucans, was effective in reducing postprandial glycemia and insulinemia, though specific statistical outcomes for \u03b2-glucans alone were not detailed in the abstract.", "population_specificity": "Normoglycemic subjects (n=40)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:48.775948+00:00"}
{"study_id": 50239, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of long-term consumption of oat-derived beta-glucan-enriched bread on glycated hemoglobin (HbA1c) in adults with pre-diabetes compared to whole-grain wheat bread.", "results_summary": "The abstract does not provide results; it describes the study design and objectives.", "population_specificity": "Adults aged 40-70 years with pre-diabetes and a BMI \u226527 kg/m\u00b2.", "effective_dosage": "Not specified", "study_duration": "16 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:49.123141+00:00"}
{"study_id": 50240, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 65, "study_goal": "The researchers aimed to determine whether beta-glucans from Aureobasidium pullulans (Nichi Glucan) could improve melatonin levels and sleep quality in children with autism spectrum disorder (ASD).", "results_summary": "The treatment group showed an increase in average serum melatonin levels and improved sleep patterns in 88% of participants, while the control group showed no improvement.", "population_specificity": "Children aged 2.5-13 years with ASD.", "effective_dosage": "1 g of Nichi Glucan daily.", "study_duration": "90 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:49.430708+00:00"}
{"study_id": 50241, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the potential of Beta-glucans as a therapeutic agent for sepsis and COVID-19 by examining their effects on immune modulation, metabolic regulation, and inflammatory responses.", "results_summary": "The study suggests Beta-glucans may help manage sepsis and COVID-19 by enhancing immune function, suppressing hyper-inflammation, modulating immune responses, and improving metabolic and coagulation parameters. Clinical studies in COVID-19 patients showed beneficial effects on inflammatory-immune events.", "population_specificity": "COVID-19 patients and sepsis cases (specific details not provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:49.629259+00:00"}
{"study_id": 50238, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effects of Nichi Glucan (Beta-glucan) on gut microbiota in children with autism spectrum disorder (ASD).", "results_summary": "The study found that Nichi Glucan supplementation reduced harmful bacteria (e.g., Enterobacteriaceae) and increased beneficial bacteria (e.g., Faecalibacterium prausnitzii) in the gut microbiome of children with ASD. It also suggested potential prophylactic benefits for neurodegenerative diseases like Parkinson's and Alzheimer's.", "population_specificity": "Children with autism spectrum disorder (ASD).", "effective_dosage": "0.5 g twice daily.", "study_duration": "90 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:50.301001+00:00"}
{"study_id": 50243, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the therapeutic potential of medicinal mushrooms, including Beta-glucans, in mitigating COVID-19 risk factors, reducing disease severity, and supporting recovery.", "results_summary": "The study highlights that medicinal mushrooms, including Beta-glucans, exhibit properties such as immunomodulation, anti-inflammatory effects, and gut microbiota enhancement, which may support COVID-19 management. However, the abstract does not provide specific efficacy data for Beta-glucans alone.", "population_specificity": "General human population, with potential relevance to COVID-19 patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:50.765033+00:00"}
{"study_id": 50242, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of fungal metabolites, particularly Beta-glucans, in cancer mycotherapy and their potential as an immune-boosting adjunct therapy for post-surgical cancer patients undergoing chemotherapy.", "results_summary": "The study suggests that Beta-glucans stimulate Dectin receptors, functioning similarly to cytokine therapy, and may enhance immune status in stage 3 cancer patients post-surgery. Evidence-based tools were recommended to quantify the effects of combined treatment, including mushroom extracts.", "population_specificity": "Stage 3 cancer patients who underwent surgery to remove the primary tumor and are receiving chemotherapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:50.983865+00:00"}
{"study_id": 50248, "supplement_id": 925, "safety_score": "90", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effects of beta-glucans from AFO-202 and N-163 strains on cytokine storm and coagulopathy biomarkers in COVID-19 patients.", "results_summary": "Beta-glucans supplementation led to sustained reductions in D-Dimer and IL-6 levels, improved immune cell counts (CD4+ and CD8+ T cells), and decreased NLR, particularly in the combination group (Gr. 3). No mortality or ventilation was required in any group.", "population_specificity": "24 RT-PCR positive COVID-19 patients.", "effective_dosage": "Not specified in the abstract.", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:53.884586+00:00"}
{"study_id": 50250, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the potential of Beta-glucans, derived from yeast microcapsules, as novel delivery vehicles for targeted oral drug delivery via the intestinal lymphatic system (ILS).", "results_summary": "The study highlights Beta-glucans as promising materials for ILS-targeted drug delivery, particularly for enhancing pharmacokinetic performance and mucosal immune responses, with potential applications in mRNA vaccine delivery.", "population_specificity": "Not specified (focused on mechanistic and material properties).", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:56.372217+00:00"}
{"study_id": 50252, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the immunomodulatory and disease-preventive effects of various bioactive ingredients, including Beta-glucans, in functional foods and nutraceuticals.", "results_summary": "The abstract highlights that bioactive ingredients like Beta-glucans have immunomodulatory, antioxidant, antibacterial, and antiviral properties, which may help in disease prevention, including potential benefits against COVID-19-related inflammation. However, the lack of clinical trials and awareness poses challenges for translating these findings into marketable products.", "population_specificity": "General human population (not specified further).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:58.286711+00:00"}
{"study_id": 50259, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the immunomodulatory, anticancer, and pro-apoptotic effects of \u03b2-glucans and their potential mechanisms in cancer therapy.", "results_summary": "The study found that \u03b2-glucans exhibit immune-modulating and anticancer properties, including tumor cell proliferation control and immune system activation. They also induce apoptotic death in cancer cells, suggesting potential therapeutic applications.", "population_specificity": "Not specified (general focus on cancer cells and immune response).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:58.355006+00:00"}
{"study_id": 50256, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the immunomodulatory, anti-inflammatory, and cardiovascular benefits of \u03b2-glucans from mushrooms and cereals, as well as their potential clinical applications in conditions like recurrent infections, cancer, and metabolic health.", "results_summary": "The study found that \u03b2-glucans from mushrooms exhibit immunomodulatory and anti-inflammatory effects, with potential clinical uses in respiratory infections, surgery complications, and as a cancer therapy adjuvant. Oat and barley \u03b2-glucans showed cardiovascular benefits, though human studies for mushroom \u03b2-glucans are needed.", "population_specificity": "Not specified (review of cellular, experimental, and potential clinical models)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:59.014445+00:00"}
{"study_id": 50254, "supplement_id": 925, "safety_score": "80", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the effects of L. edodes (shiitake) bars, rich in \u03b2-glucans, on cholesterol levels and oxidative stress in individuals with borderline high cholesterol.", "results_summary": "The study found a 10% reduction in triglycerides and improved redox status (increased reduced glutathione, reduced lipid peroxidation) after 66 days of consuming shiitake bars, though 10% of sensitive individuals experienced dermatitis.", "population_specificity": "Individuals with borderline high cholesterol, low-density lipoprotein, or triglycerides.", "effective_dosage": "Not specified (bars were consumed, but exact \u03b2-glucan dosage not detailed).", "study_duration": "66 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:02:59.144938+00:00"}
{"study_id": 50260, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the cardioprotective effects of bioprocessed oat bran (rich in beta-glucans) and its potential additive or synergistic effects with bilberry on cardiometabolic risk factors post-AMI.", "results_summary": "The study is designed to evaluate the difference in LDL cholesterol change and exercise capacity after 3 months of intervention with oat bran, bilberry, or their combination, compared to a reference supplement. Results are pending as the study is ongoing.", "population_specificity": "900 patients post-PCI for acute myocardial infarction (AMI).", "effective_dosage": "Beverages with high-fiber bioprocessed oat bran consumed twice daily (exact dosage not specified).", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:00.525223+00:00"}
{"study_id": 50261, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize recent developments in the isolation, structural features, bioactivities, and mechanisms of polysaccharides (especially \u03b2-glucans) from Lentinus edodes, focusing on their potential as therapeutic agents and functional foods.", "results_summary": "The study found that L. edodes polysaccharides exhibit significant biological activities, including anti-oxidant, anti-tumor, anti-aging, anti-inflammatory, immunomodulatory, antiviral, and hepatoprotective effects. The review highlights their structure-activity relationship and potential applications.", "population_specificity": "Not specified (general review of existing research).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:02.813955+00:00"}
{"study_id": 50262, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of a combination of red yeast rice (containing 10 mg monacolin K) and beta-glucans in managing blood cholesterol levels.", "results_summary": "The study found significant reductions in LDL cholesterol and total cholesterol compared to placebo, with a mean difference of 23.6 \u00b1 1.5 mg/dL. The combination showed promising effects in statin-na\u00efve or statin-intolerant patients.", "population_specificity": "Adult patients with total cholesterol \u2265200 mg/dL, either statin-na\u00efve or recently stopped statin treatment due to intolerance.", "effective_dosage": "Not specified for beta-glucans (only monacolin K dosage mentioned: 10 mg).", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:05.550647+00:00"}
{"study_id": 50266, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the extraction techniques, structure, and therapeutic applications of bioactive polysaccharides, particularly \u03b2-glucans, in mushrooms and their potential role in modulating immunity.", "results_summary": "The study highlighted that \u03b2-glucans, a major component of mushroom cell walls, contribute to various biological activities, including immunomodulatory, antimicrobial, and antitumor effects, suggesting their potential as functional medicinal foods.", "population_specificity": "Not specified (general human welfare focus)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:06.255707+00:00"}
{"study_id": 50265, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the diverse functional properties of \u03b2-glucans and their distinct clinical applications in managing conditions like cancer, diabetes, gastrointestinal disorders, and cardiovascular diseases.", "results_summary": "The study found that \u03b2-glucans exhibit varied clinical functions based on their physiochemical properties, influencing immune stimulation, prebiotic effects, and modulation of physiological events. It highlighted their potential in wound care, metabolic dysbiosis, fatty liver disorders, and energy metabolism during endurance training.", "population_specificity": "Not specified (review of clinical applications).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:06.888695+00:00"}
{"study_id": 50267, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of postbiotics, including \u03b2-glucans, in cancer prevention and therapy.", "results_summary": "The study highlights \u03b2-glucans as a promising postbiotic with potential anticancer effects, though it notes contradictory roles in healthy versus tumor tissues. The abstract suggests \u03b2-glucans may contribute to establishing an anticancer environment in the body.", "population_specificity": "Not specified (general discussion of postbiotics in cancer contexts).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:07.057574+00:00"}
{"study_id": 50268, "supplement_id": 925, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to review the molecular structure, antitumor immune activities, structure-activity relationship, and clinical trials of soluble \u03b2-glucans to assess their potential as immunostimulants in cancer treatment.", "results_summary": "The study found that soluble \u03b2-glucans activate pro-inflammatory responses in immune cells, enhance antitumor defense, and have been widely used in clinical antitumor studies as immunostimulants. Their biological activities include lipid-lowering, hypoglycemic, and immune regulation effects.", "population_specificity": "Cancer patients (clinical studies) and general immune cell research (in vitro/in vivo).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:09.035241+00:00"}
{"study_id": 50270, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine the effects of Agaricus bisporus (containing beta-glucans) on human health outcomes and determine the nutrient density of its bioactive compounds.", "results_summary": "The study found beneficial effects of A. bisporus on metabolic syndrome, immune function, gastrointestinal health, and cancer, with strong evidence for improved Vitamin D status. Beta-glucans were identified as one of the bioactive compounds, but their specific effects were not isolated.", "population_specificity": "General human population (no specific subgroup mentioned).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:09.169151+00:00"}
{"study_id": 50251, "supplement_id": 925, "safety_score": "90", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine whether fortifying a meal with \u03b2-glucans from oyster mushrooms could improve postprandial glucose and triglyceride responses by enhancing gastrointestinal hormone release in individuals with impaired glucose tolerance.", "results_summary": "The study found no significant differences in postprandial glucose, insulin, triglycerides, GIP, or ghrelin levels between the enriched and control meals. However, NEFAs-AUC was 14% lower and GLP-1-AUC was 17% higher after the enriched meal, and hunger AUC was 22% lower.", "population_specificity": "22 subjects with impaired glucose tolerance (IGT).", "effective_dosage": "20 g powder (containing 8.1 g \u03b2-glucans) of oven-dried Pleurotus ostreatus per meal.", "study_duration": "Single meal intervention with blood collection over 4 hours postprandially.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:10.184742+00:00"}
{"study_id": 50271, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of regular consumption of Lipigo (containing Beta-glucans) on individuals with a BMI of 25-39.9 kg/m\u00b2.", "results_summary": "The study involved 120 subjects, predominantly women, with an average BMI of 31.19 kg/m\u00b2. The abstract does not provide specific results on the efficacy of Lipigo, only mentioning the study's conclusion about its regular consumption.", "population_specificity": "Adults (49.0 \u00b1 9.5 years old) with a BMI of 25-39.9 kg/m\u00b2 (81.57 \u00b1 13.26 kg body weight).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:12.381935+00:00"}
{"study_id": 50272, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to explore the antitumor effects of Beta-glucans as a constituent of gut microbiota, focusing on their potential role in treating or preventing colorectal cancer.", "results_summary": "The abstract suggests that Beta-glucans, as part of bacterial cell walls, exhibit antitumor effects in the host, contributing to potential therapeutic methods for colorectal cancer. However, specific mechanisms and outcomes are not detailed.", "population_specificity": "Not specified (general focus on colorectal cancer and gut microbiota).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:13.899407+00:00"}
{"study_id": 50273, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate the systematic mechanism of functional ingredients in barley, including Beta-glucans, in combating chronic diseases.", "results_summary": "The study found that barley and its extracts contain multiple functional ingredients, including Beta-glucans, which may combat over 20 chronic diseases, with some differences in efficacy between grains and grass. The major molecular mechanisms involve six key functional ingredients in barley grass and grains.", "population_specificity": "Not specified (general chronic disease context).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:14.461203+00:00"}
{"study_id": 50277, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the current evidence on yeast-derived \u03b2-glucans as immunomodulators, focusing on their interaction with the immune system and their potential to enhance immune responses.", "results_summary": "Pre-clinical studies suggest \u03b2-1,3/1,6-glucan may improve immuno-surveillance, but human evidence is less robust. The abstract highlights uncertainty and the need for further research to clarify \u03b2-glucan's effects on human immune function.", "population_specificity": "Not specified (review of pre-clinical and human studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:15.823501+00:00"}
{"study_id": 50276, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to assess how immunogenicity risk, influenced by factors like host expression systems and impurities (including beta-glucans), affects the development of a recombinant therapeutic protein for autoimmune conditions.", "results_summary": "The abstract discusses how different expression systems (e.g., CHO cells, Pichia pastoris) introduce varying levels of product-related variants and impurities (e.g., beta-glucans), which may impact immunogenicity risk, but does not report specific findings on beta-glucans' effects.", "population_specificity": "Not specified (hypothetical recombinant protein development for autoimmune conditions).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:16.068922+00:00"}
{"study_id": 50283, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to review the cholesterol-lowering effects of Beta-glucans among other substances found in functional foods or nutraceuticals.", "results_summary": "The abstract indicates that Beta-glucans are effective in lowering cholesterol, either alone or in combination with other preparations, but emphasizes the need for physician consultation before use.", "population_specificity": "Patients with increasing lipid abnormalities or cardiovascular risk.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:17.271211+00:00"}
{"study_id": 50281, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether a two-day oatmeal diet (rich in Beta-glucans) could reduce bile acid concentrations in patients with uncontrolled type 2 diabetes compared to a conventional diabetes-adapted diet.", "results_summary": "The study found that two days of oatmeal treatment significantly reduced total bile acids and glycocholic acid compared to the control diet. The reduction in bile acids correlated with a decrease in proinsulin, suggesting potential benefits for glucose homeostasis.", "population_specificity": "15 patients with uncontrolled type 2 diabetes in an inpatient clinical setting.", "effective_dosage": "Not specified (oatmeal diet provided, but exact Beta-glucan dosage not detailed).", "study_duration": "Two days per dietary intervention (oatmeal vs. control).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:18.426477+00:00"}
{"study_id": 50279, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effects of 3 g/day oat beta-glucans on plasma lipids, fasting glucose, and self-perceived intestinal well-being in individuals with moderate hypercholesterolemia.", "results_summary": "Beta-glucans significantly reduced LDL-Cholesterol levels by 12.2% after 4 weeks and 15.1% after 8 weeks of supplementation, indicating a clinically meaningful improvement in lipid profile. No results on fasting glucose or intestinal well-being were reported in the abstract.", "population_specificity": "83 Italian free-living subjects adhering to a Mediterranean diet, with moderate hypercholesterolemia and low cardiovascular risk.", "effective_dosage": "3 g/day", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:18.433243+00:00"}
{"study_id": 50284, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the immune-modulating effects of Beta-glucans in tumor-bearing animal models and their potential efficacy in cancer patients.", "results_summary": "Beta-glucans showed promising immune-modulating effects, such as inhibiting myeloid-derived suppressor cells and enhancing natural killer and cytolytic T cells in tumor-bearing animal models, but their efficacy in cancer patients remains undetermined.", "population_specificity": "Tumor-bearing animal models and potential implications for cancer patients (human clinical trials not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:20.364979+00:00"}
{"study_id": 50285, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the possible role of Beta-glucans as a supportive therapy in managing patients with dyslipidemias, particularly in reducing LDL-C levels.", "results_summary": "The abstract mentions Beta-glucans as one of the most investigated nutraceuticals with good tolerability and lipid-lowering effects, but specific efficacy data or results for Beta-glucans are not detailed.", "population_specificity": "Patients with dyslipidemias or high cardiovascular risk.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:21.815566+00:00"}
{"study_id": 50288, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review evidence on the types, functional properties, and mechanisms by which \u03b2-glucans regulate gut microbiota and human health.", "results_summary": "The study summarizes that \u03b2-glucans exhibit various biological activities, including anticancer, antidiabetic, anti-inflammatory, and immune-modulating effects, and significantly impact gut microbiota changes, thereby influencing human health.", "population_specificity": "Not specified (review of in vitro, in vivo, and clinical studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:22.497402+00:00"}
{"study_id": 50289, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the potential of Beta-glucans and other phytochemicals to inhibit immunosuppressive MDSCs in cancers and chronic inflammatory diseases.", "results_summary": "The abstract suggests Beta-glucans possess MDSC-dependent antitumor and anti-inflammatory properties, aligning with the broader therapeutic benefits of herbal medicine. However, specific efficacy data or clinical outcomes for Beta-glucans are not detailed.", "population_specificity": "Not specified (general focus on cancers and chronic inflammatory diseases).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:23.734172+00:00"}
{"study_id": 50290, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the cholesterol-lowering effects of Beta-glucans as part of functional foods or supplements.", "results_summary": "The study found that Beta-glucans, along with other cholesterol-lowering substances, can effectively reduce plasma LDL cholesterol levels by about 5 to 25%, either alone or in combination. Suitable candidates are mainly individuals at low absolute cardiovascular risk.", "population_specificity": "Individuals at low absolute cardiovascular risk, particularly at a young age or according to classic algorithms.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:24.296355+00:00"}
{"study_id": 50291, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the immunobiology of fungal \u03b2-glucans, their role as pathogen-associated molecular patterns, and their potential clinical utility as biological response modifiers for treating cancer and infectious diseases.", "results_summary": "The study found that \u03b2-glucans modulate immune responses by binding to receptors on innate immune cells, with effects varying by cell type, receptor, and \u03b2-glucan source. Purified \u03b2-glucans show promise as therapeutic agents for antifungal, anti-infective, and antitumor applications, though data interpretation is complicated by the use of crude extracts in many studies.", "population_specificity": "Not specified (review of existing studies).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:26.863231+00:00"}
{"study_id": 50293, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the potential of \u03b2-glucan and \u03b2-glucan-based nanoparticles as immune modulators of the tumor microenvironment (TME) and their therapeutic applications in cancer immunotherapy.", "results_summary": "The study found that \u03b2-glucans and their nanoparticles can actively manipulate the TME to enhance antitumor immunity, suggesting their potential as adjuvants in combination cancer immunotherapies. Emerging data indicate these molecules target immune cell receptors, improving immune responses.", "population_specificity": "Not specified (review of preclinical and clinical data).", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:27.081335+00:00"}
{"study_id": 50294, "supplement_id": 925, "safety_score": "90", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the potential of \u03b2-glucans as a therapeutic option for reducing cholesterol levels in patients with dyslipidemia.", "results_summary": "The study found that \u03b2-glucans, particularly soluble forms, interact with lipids and biliary salts in the digestive tract, leading to reduced cholesterol levels. The abstract suggests \u03b2-glucans are a natural and safe option with minimal side effects.", "population_specificity": "Patients with dyslipidemia or hypercholesterolemia (not further specified).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:27.785881+00:00"}
{"study_id": 50292, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the potential of plant lectins and \u03b2-glucans, particularly from mushrooms, in cancer prevention and treatment, focusing on their biological activities and mechanisms.", "results_summary": "The study highlights that \u03b2-glucans, especially those with \u03b2-(1\u21923)-glycosidic bonds, may modulate immune responses by interacting with specific receptors, showing cytotoxic, antitumor, antimutagenic, and anticarcinogenic properties. The effects depend on their structural characteristics like conformation, bonds, and molecular size.", "population_specificity": "Not specified (literature review, not a clinical study).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:28.511906+00:00"}
{"study_id": 50295, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the cholesterol-lowering mechanisms of fungal extracts, including \u03b2-glucans, compared to pharmaceutical drugs and functional foods.", "results_summary": "The study found that fungal \u03b2-glucans and other compounds modulated cholesterol levels by down-regulating genes involved in cholesterol homeostasis and mimicking the effects of hypocholesterolemic drugs like simvastatin or ezetimibe. These effects were observed in both in vitro and in vivo studies.", "population_specificity": "Not specified (in vitro and in vivo models mentioned, but no human population details provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:30.167802+00:00"}
{"study_id": 50296, "supplement_id": 925, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to review the clinical and physiological importance of \u03b2-glucans and compare their biological activities through existing in vitro and in vivo studies.", "results_summary": "The study found that \u03b2-glucans exhibit antitumor, anti-inflammatory, anti-obesity, anti-allergic, anti-osteoporotic, and immunomodulating activities, supported by in vitro, animal, and human clinical studies. However, systematic clinical studies on \u03b2-glucans are limited.", "population_specificity": "Not specified (includes in vitro, animal, and human studies).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:31.280691+00:00"}
{"study_id": 50297, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of Beta-glucans as an immunomodulator for treating and preventing recurrent respiratory tract infections (RRTIs) in children and adults.", "results_summary": "The study found that Beta-glucans exhibit immunomodulatory, anti-inflammatory, and anti-infectious activities, suggesting their effectiveness in managing and preventing RRTIs, particularly in children.", "population_specificity": "Children with recurrent respiratory tract infections and adults under conditions like stress, chronic inflammatory diseases, or secondary immunodeficiencies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:32.871807+00:00"}
{"study_id": 50298, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the immunomodulatory properties of yeast cell wall \u03b2-glucans and their potential applications in whole yeast vaccines and biopharmaceutical production.", "results_summary": "The study highlighted the immunomodulatory properties of yeast cell wall \u03b2-glucans and their role in expanding yeast applications as a vaccine platform, including intracellular expression of pathogen/tumor antigens. It also noted the potential advantages of Pichia pastoris over Saccharomyces cerevisiae for biopharmaceutical production due to higher biomass yield and glycosylation similarity to mammals.", "population_specificity": "Not specified (review of general and patent-oriented insights)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:33.029727+00:00"}
{"study_id": 50299, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the potential of yeast polysaccharides, including beta-glucans, as hypolipidemic agents for treating hypercholesterolemia, either alone or in combination with statins.", "results_summary": "The abstract suggests beta-glucans are being explored as a natural alternative or adjunct to statins for cholesterol management, but specific efficacy data or outcomes are not detailed.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:34.698538+00:00"}
{"study_id": 50304, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review the clinical effects, mechanism of action, and safety profile of Beta-glucans among other dietary supplements for weight management.", "results_summary": "The abstract does not provide specific findings about Beta-glucans, only mentioning it as one of the supplements reviewed.", "population_specificity": "Not specified", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:35.359389+00:00"}
{"study_id": 50302, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize and evaluate the nutritional and therapeutic uses of Agaricus blazei, with a focus on its chemical composition (including \u03b2-glucans) and clinical investigations.", "results_summary": "The study found that \u03b2-glucans from Agaricus blazei exhibit multiple bioactivities, including immunomodulation, anti-inflammatory effects, anticancer properties, and antidiabetic activity, supported by experimental evidence. However, clinical evidence is limited, with only 17 clinical studies and two case reports identified.", "population_specificity": "Not specified (general human health and disease contexts implied).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:35.765457+00:00"}
{"study_id": 50303, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to review the literature on beta-glucans in pharmaceutical products and propose an acceptable level for therapeutic agents for parenteral use.", "results_summary": "The study highlights beta-glucans' immunostimulatory properties and their use as anti-microbial and anti-tumour agents, but notes uncertainty about immunostimulation thresholds and contamination risks in pharmaceutical products. It also suggests regulators may increasingly scrutinize beta-glucan levels in immunomodulatory drugs.", "population_specificity": "Not specified (literature review)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:35.920942+00:00"}
{"study_id": 50306, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the scientific evidence supporting the efficacy of bioactive compounds, including beta-glucans, in preventing and treating cardiovascular diseases.", "results_summary": "The study found that certain doses of beta-glucans can help decrease the prevalence of CVD risk factors, though further rigorous evidence is needed to confirm their effects.", "population_specificity": "Humans (specific population details not provided in the abstract).", "effective_dosage": "Certain doses (specific amounts and frequency not detailed in the abstract).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:39.111832+00:00"}
{"study_id": 50305, "supplement_id": 925, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of a \u03b2-glucan-based cream (Imunoglukan P4H\u00ae) as a supportive complementary therapy for atopic dermatitis by assessing its effects on symptom severity and patient-reported outcomes.", "results_summary": "The study found that topical \u03b2-glucan application significantly improved both objective (EASI score) and subjective (VAS score) symptoms of atopic dermatitis, reduced the number of days with exacerbations, and decreased pruritus severity. The preparation was generally well tolerated.", "population_specificity": "105 patients with atopic dermatitis (39 males, 37%).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:40.100557+00:00"}
{"study_id": 50308, "supplement_id": 925, "safety_score": "90", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether barley's beta-glucan could inhibit alterations in intestinal permeability and maintain intestinal integrity after daily consumption of a sugar-rich carbohydrate snack.", "results_summary": "The study found no significant difference in intestinal permeability between the beta-glucan-fortified cake group and the placebo group, indicating that beta-glucans did not exert a protective role in intestinal permeability for healthy adults.", "population_specificity": "Twenty-three healthy volunteers aged over 40 years.", "effective_dosage": "One portion of beta-glucan-fortified cake daily (exact beta-glucan dosage not specified).", "study_duration": "1 month.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:41.675068+00:00"}
{"study_id": 50307, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effectiveness of beta-glucans, along with pectins and alginates, in beverages and liquid meals for enhancing satiety and appetite control.", "results_summary": "The review found consistent evidence that beta-glucans, pectins, and alginates in beverages or liquid test meals effectively enhance satiety and appetite control. However, the impact of common food processing on these fibres' properties was largely unaddressed, highlighting a research gap.", "population_specificity": "Human intervention studies (specific demographics not detailed in the abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:41.965586+00:00"}
{"study_id": 50309, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to explore the therapeutic potential of Beta-glucans in reducing low-density-lipoprotein cholesterol levels and improving brain function.", "results_summary": "The abstract suggests that Beta-glucans, among other natural products, may support improved brain function and reduce LDL cholesterol levels, though specific results for Beta-glucans alone are not detailed.", "population_specificity": "Not specified (general mention of natural products for brain health and cholesterol management).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:42.155396+00:00"}
{"study_id": 50311, "supplement_id": 925, "safety_score": "90", "efficacy_score": 10, "quality_score": 70, "study_goal": "The researchers aimed to determine whether oral \u03b2-glucan enhances innate immune responses in humans by measuring serum levels, cytokine production, and microbicidal activity of leukocytes.", "results_summary": "The study found that \u03b2-glucan was barely detectable in serum and did not affect cytokine production or microbicidal activity of leukocytes, suggesting no immunostimulatory effect from oral administration.", "population_specificity": "15 healthy male volunteers (10 in \u03b2-glucan group, 5 controls).", "effective_dosage": "1000 mg once daily.", "study_duration": "7 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:43.797281+00:00"}
{"study_id": 50310, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of Beta-glucans, among other functional components, on lipid profiles and postprandial glucose response in young, slightly overweight individuals with dyslipidemia or near-dyslipidemia.", "results_summary": "The study found a statistically significant reduction in lipid profile markers and a significantly lower glycemic response after a meal enriched with Beta-glucans compared to a non-enriched meal.", "population_specificity": "Young (20-37 years), slightly overweight individuals with normal glucose tolerance and dyslipidemia or near-dyslipidemia.", "effective_dosage": "Not specified", "study_duration": "4 weeks (run-in phase) plus intervention duration (not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:44.448486+00:00"}
{"study_id": 50312, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the biological and technological potential of chemically modified D-glucans, focusing on their enhanced activities such as antioxidation, anticoagulation, antitumor, and antiviral effects.", "results_summary": "The review highlights that chemical modifications (sulfonylation, carboxymethylation, phosphorylation, acetylation) of D-glucans improve their solubility and biological activities, showing potentiated effects as anticoagulants, antitumors, antioxidants, and antivirals. Several studies suggest these modified glucans have significant potential for treating and preventing various human diseases.", "population_specificity": "Not specified (review of existing studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:45.255584+00:00"}
{"study_id": 50313, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to identify potential antigens, including Beta-glucans, for vaccine development against Candida infections.", "results_summary": "The abstract suggests Beta-glucans are among several antigens useful for vaccine development, with broad experience in animal models, but no specific results on Beta-glucans' efficacy are detailed.", "population_specificity": "Animal models (rabbits and mice) and implied human applications for immune-deficient individuals.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:46.701911+00:00"}
{"study_id": 50314, "supplement_id": 925, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether orally administered beta-glucans, particularly insoluble yeast beta-glucans, can modulate the immune system and are safe for human consumption.", "results_summary": "The study found that orally applied beta-glucans exert immune-modulating effects, supported by receptor interactions and clinical trials. Results confirmed safety and immune-strengthening effects of insoluble yeast beta-glucans.", "population_specificity": "Human clinical trials (specific population not detailed in abstract).", "effective_dosage": "Not specified in abstract.", "study_duration": "Not specified in abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:48.259459+00:00"}
{"study_id": 50316, "supplement_id": 925, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the immunomodulatory effects of yeast-derived beta-glucans (Y-BG) on infection resistance, immune markers, and potential anticarcinogenic properties in various populations.", "results_summary": "Orally administered Y-BG reduced upper respiratory tract infections in susceptible individuals, improved immune markers (e.g., salivary IgA, IL-10), and showed protective effects in animal models against infections, stress-induced cytokines, and drug intoxication. However, effects varied by population and preparation characteristics.", "population_specificity": "Individuals susceptible to upper respiratory infections, healthy individuals, obese subjects, allergic patients, and cancer patients.", "effective_dosage": "7.5-1500 mg/day (varied by study)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:51.287192+00:00"}
{"study_id": 50315, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the beneficial effects of Beta-glucans and other mushroom-derived compounds on metabolic syndrome symptoms, including hypoglycaemic, cholesterol-lowering, hypotensive, and weight management effects.", "results_summary": "The study found that Beta-glucans and other mushroom compounds effectively lowered blood sugar, cholesterol, and triglycerides, reduced blood pressure, and aided weight management by influencing satiety. The most active compounds identified were polysaccharides (\u03b2-glucans), lectins, and small molecules like eritadenin, triterpenes, sterols, and phenolic compounds.", "population_specificity": "Individuals with metabolic syndrome (central obesity, hyperglycaemia, hypercholesterolemia, hypertension).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:51.301946+00:00"}
{"study_id": 50323, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the biological activities, mode of action, and clinical applications of lentinan (a \u03b2-glucan) in treating gastric cancer, including its potential synergistic effects with monoclonal antibodies.", "results_summary": "Lentinan, when used in chemo-immunotherapy, prolongs survival in advanced gastric cancer patients compared to chemotherapy alone. It may synergize with anti-cancer monoclonal antibodies by activating complement systems through antibody-dependent and complement-dependent cytotoxicity.", "population_specificity": "Patients with advanced, unresectable, or recurrent gastric cancer.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Potential synergistic action with trastuzumab (anti-HER2/neu antibody) and cytotoxic chemotherapeutic agents.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:51.971184+00:00"}
{"study_id": 50324, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the immunomodulatory effects of different \u03b2-glucans, particularly pleuran, on reducing upper respiratory tract infections (URTIs) in endurance athletes.", "results_summary": "Pleuran, an insoluble \u03b2-glucan from Pleurotus ostreatus, significantly reduced URTI incidence and increased natural killer cell activity in athletes, while soluble oat \u03b2-glucan showed no effect. The study suggests \u03b2-glucan efficacy depends on solubility and structural factors.", "population_specificity": "Endurance athletes", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:52.242859+00:00"}
{"study_id": 50325, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether combining Beta-glucans with other dietary components could additively reduce LDL-cholesterol levels.", "results_summary": "Beta-glucans, when consumed individually at their target rate, reduced LDL-cholesterol by 3-9%. Combining them with other dietary interventions showed largely additive effects, contributing to significant LDL-cholesterol reductions.", "population_specificity": "General population with elevated LDL-cholesterol (specific demographics not detailed).", "effective_dosage": "Target rate (specific dosage not provided).", "study_duration": "Clinical efficacy studies (~1 month) and community-based studies (>6 months).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:53.352004+00:00"}
{"study_id": 50326, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the nutritional, chemical, and biological aspects of mushroom polysaccharides, particularly \u03b2-glucans, to elucidate the correlation between their structural features and biological functions.", "results_summary": "The study found that \u03b2-glucans exhibit antitumor and immunostimulating properties, stimulating immune responses via various receptors. Clinical products derived from \u03b2-glucans, such as schizophyllan and lentinan, have shown evident clinical results.", "population_specificity": "Not specified (general review of existing research).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:53.454949+00:00"}
{"study_id": 50328, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the physiological effects and health implications of nonstarch polysaccharides, particularly Beta-glucans, in relation to diet-related diseases and therapeutic applications.", "results_summary": "The study found that soluble NSPs like Beta-glucans lower plasma cholesterol, normalize blood glucose and insulin levels, and promote beneficial colonic bacteria through fermentation into SCFAs, aiding in cardiovascular and metabolic health.", "population_specificity": "General human population, with implications for those with cardiovascular diseases and Type 2 diabetes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:54.792520+00:00"}
{"study_id": 50329, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to characterize the role of L-ficolin in innate immunity, particularly its binding affinity for 1,3-\u03b2-glucans and its potential role in respiratory immunity.", "results_summary": "The study found that L-ficolin recognizes 1,3-\u03b2-glucans among other molecular patterns and may play a role in innate immunity, particularly in respiratory defense against pathogens like Pseudomonas aeruginosa.", "population_specificity": "Not specified (general human immunity context)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:56.365904+00:00"}
{"study_id": 50331, "supplement_id": 925, "safety_score": "85", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of barley-derived beta-glucan on gut microbiota in polypectomized patients.", "results_summary": "The study found no significant differences in bacterial counts between groups, but noted reduced coliform counts and changes in volatile fatty acid ratios in the beta-glucan group. Gastrointestinal symptoms like bloating and abdominal pain also decreased in the beta-glucan group.", "population_specificity": "Polypectomized men and women (mean age 57.6 years).", "effective_dosage": "3 g/day (consumed via 125 g of bread daily).", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:03:59.733184+00:00"}
{"study_id": 50333, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to provide a comprehensive commentary on \u03b2-glucans, including their chemistry, functional role in immunological responses, and potential therapeutic applications.", "results_summary": "The study found that \u03b2-glucans offer a range of health benefits, particularly in promoting healthy cholesterol and blood glucose levels for cardiovascular health and enhancing immune system functions against cancer. The mechanisms behind these benefits are not yet fully understood.", "population_specificity": "Not specified (broadly applicable to humans based on context).", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:00.272640+00:00"}
{"study_id": 50332, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of beta-glucan-enriched foods versus rice bran-enriched foods on lipid profiles in mildly hypercholesterolemic men.", "results_summary": "Beta-glucan-enriched foods were more effective than rice bran-enriched foods in lowering LDL cholesterol and total cholesterol levels, with statistically significant differences observed. Other lipid and glucose parameters were not significantly affected by either diet.", "population_specificity": "Mildly hypercholesterolemic men (mean age: 50.3\u00b15.3, mean BMI: 24.9\u00b11.9).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Each intervention diet period lasted 4 weeks, with a 3-week wash-out between periods.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:00.405807+00:00"}
{"study_id": 50334, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "To examine the immune-modulating effects of \u03b2-glucans and their potential benefits in infection and cancer, particularly when combined with cancer therapy.", "results_summary": "\u03b2-Glucans show promise in enhancing immune function and reducing susceptibility to infection and cancer, with recent human trials indicating benefits in quality of life and survival when used alongside cancer treatment. However, most evidence is preclinical, and human studies are still emerging, limiting firm clinical conclusions.", "population_specificity": "General immune function and cancer patients (specific population not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:00.537445+00:00"}
{"study_id": 50337, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the hematopoiesis-promoting effects of orally administered beta-glucans and their potential additive effect with G-CSF in cyclophosphamide-conditioned mice.", "results_summary": "Beta-glucan alone did not enhance granulopoiesis but significantly improved monocyte recovery in leukopenic mice. When co-administered with G-CSF, it showed a weak additive effect on granulopoiesis.", "population_specificity": "Cyclophosphamide-conditioned mice (leukopenic model).", "effective_dosage": "Not specified (administered for 5 consecutive days).", "study_duration": "5 days.", "interactions": "Co-administered with recombinant human G-CSF (filgrastim).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:02.286296+00:00"}
{"study_id": 50335, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of consuming alpha-glucans from A. bisporus on ex vivo cytokine production by human peripheral blood mononuclear cells (PBMCs) in mildly hypercholesterolemic subjects.", "results_summary": "Consumption of A. bisporus alpha-glucans reduced LPS-induced TNFalpha production by 69% compared to the control group, with no effect on IL-1beta and IL-6. No significant Th1-Th2 skewing was observed, though there was a trend toward decreased IL-12 and IL-10 production.", "population_specificity": "Mildly hypercholesterolemic subjects (N=56)", "effective_dosage": "5 g alpha-glucans/day", "study_duration": "5 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:02.621963+00:00"}
{"study_id": 181366, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify mRNA expression patterns associated with Baker's Yeast Beta Glucan (BYBG) following exercise, focusing on innate immune response.", "results_summary": "The study analyzed mRNA expression in blood samples collected at multiple time points post-exercise, comparing BYBG (Wellmune\u00ae) to placebo. Results indicated BYBG influenced innate immune response mRNA expression, though specific outcomes were not detailed in the abstract.", "population_specificity": "Participants were randomized to BYBG (N=9) or placebo (N=10), undergoing 90 minutes of whole-body exercise.", "effective_dosage": "Not specified in the abstract.", "study_duration": "6 weeks prior to exercise.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:05.053739+00:00"}
{"study_id": 181371, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to determine the impact of yeast beta-glucan on immune system responses under aerobic exercise and thermal stress conditions.", "results_summary": "The abstract does not provide specific results regarding the effects of beta-glucans.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:07.021584+00:00"}
{"study_id": 181367, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of whole grain Avena sativa and Hordeum vulgare L., or their isolated fractions, on immune and inflammatory functions, as well as their influence on gut microbiota.", "results_summary": "The study found that oats and barley consumption may confer anti-inflammatory effects in metabolically at-risk populations and influence gut microbiota outcomes, but no anti-inflammatory benefits were observed in healthy individuals. Significant reductions in inflammatory biomarkers were reported in long-term studies involving metabolically at-risk populations.", "population_specificity": "Adults, including metabolically at-risk individuals (overweight, obesity, metabolic syndrome, hypercholesterolemia), young healthy individuals, older individuals (aged over 50 years), and populations with other disease states.", "effective_dosage": "Not specified", "study_duration": "Short-term (up to 14 days) and long-term (beyond 14 days, up to 90 days)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:07.222436+00:00"}
{"study_id": 181368, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of Beta-glucans, as a prebiotic, on colorectal neoplasia incidence among adults.", "results_summary": "The study found no association between prebiotic supplementation (including Beta-glucans) and colorectal neoplasia risk.", "population_specificity": "Adults aged \u226518 without baseline gastrointestinal disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:08.495462+00:00"}
{"study_id": 181370, "supplement_id": 925, "safety_score": "95", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the health effects of consuming fungal beta-(1\u21923,1\u21926)-d-glucans, focusing on immunomodulation, psychological wellbeing, and potential benefits for obesity-related conditions and cancer therapy support.", "results_summary": "The study found that fungal beta-glucans primarily enhanced immune defense, reducing respiratory infections and improving allergic symptoms, while also benefiting psychological wellbeing and potentially aiding obesity-related conditions. However, immune response alterations were inconsistent at cellular and molecular levels, and no adverse events were reported.", "population_specificity": "Healthy subjects and patients, including overweight/obese adults and those undergoing cancer therapies.", "effective_dosage": "2.5 to 1000 mg daily", "study_duration": "Up to 6.5 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:09.714970+00:00"}
{"study_id": 181372, "supplement_id": 925, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize the biomedical applications of medicinal mushrooms, including Beta-glucans, and highlight critical unsolved problems in their production, standardization, and safety.", "results_summary": "The study highlights the diverse applications of medicinal mushrooms, including Beta-glucans, in dietary supplements, pharmaceuticals, and biocontrol agents, but notes unresolved issues in standardization and safety.", "population_specificity": "Not specified (general discussion of medicinal mushrooms and their applications).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:10.063378+00:00"}
{"study_id": 181369, "supplement_id": 925, "safety_score": "80", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential applications of fungal beta-glucans in nutrition and medicine, focusing on their immunomodulating effects, safety, and efficacy.", "results_summary": "The study found that fungal beta-glucans have immunomodulating properties and could support immune health, potentially qualifying for health claims if approved. They may also hold promise in Western medicine due to the emerging concept of trained immunity.", "population_specificity": "Not specified (general discussion, not a clinical trial).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:10.064734+00:00"}
{"study_id": 181373, "supplement_id": 925, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether \u03b2-glucans could improve LDL cholesterol levels and glycemic control in myasthenia gravis (MG) patients, who often experience muscle-related side effects from statins.", "results_summary": "The study found a significant reduction in total cholesterol, LDL, ApoA1, and ApoB after 8 weeks of \u03b2-glucan supplementation, but no changes in glycemic control or BMI. \u03b2-glucans may improve lipid status in MG patients without the muscle-related side effects of statins.", "population_specificity": "59 patients with myasthenia gravis (52 completed the study).", "effective_dosage": "3 g daily.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:12.018923+00:00"}
{"study_id": 3705, "supplement_id": 926, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to explore the protective effect and potential mechanism of betaine on early fatty liver syndrome (FLS) in caged laying hens.", "results_summary": "Betaine supplementation significantly alleviated serum and hepatic lipid accumulation caused by dexamethasone treatment, rescued differential gene expression related to lipid metabolism and antioxidant functions, and reversed upregulated lipid synthesis pathways.", "population_specificity": "Caged laying hens", "effective_dosage": "8 g/kg betaine in diet", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:12.496622+00:00"}
{"study_id": 3706, "supplement_id": 926, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether betaine could mitigate hepatotoxicity induced by polyethylene terephthalate nanoplastics (PET-NPs) in mice.", "results_summary": "Betaine treatment reduced PET-NP-induced hepatotoxicity, lowering elevated liver enzymes (ALT, AST), oxidative stress (MDA), inflammatory markers (c-FOS, COX2), and improving glutathione (GSH) levels, while also ameliorating histopathological damage and reducing TNF-\u03b1 and NF-\u04a0B expression.", "population_specificity": "Adult male Swiss albino mice.", "effective_dosage": "1000 mg/kg intraperitoneally.", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:15.983232+00:00"}
{"study_id": 3707, "supplement_id": 926, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to develop a multifunctional hydrogel (CBPCa/PDA/DFO) incorporating betaine-grafted chitosan to enhance diabetic wound healing through antibacterial, anti-inflammatory, and vascular regeneration properties.", "results_summary": "The CBPCa/PDA/DFO hydrogel demonstrated improved mechanical strength, injectability, coagulation performance, and antibacterial effects under NIR stimulation. It significantly enhanced vascular regeneration and reduced inflammation in diabetic wound healing.", "population_specificity": "Diabetic wound models (in vivo study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:16.846728+00:00"}
{"study_id": 3709, "supplement_id": 926, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether foliar application of 2,4-epibrassinolide (EBR) could mitigate salt stress in pepper plants by promoting sugar and glycine betaine accumulation.", "results_summary": "EBR treatment significantly increased proline, sugar, and glycine betaine levels in salt-stressed pepper seedlings, enhancing antioxidant defense mechanisms and reducing ROS and MDA accumulation.", "population_specificity": "Pepper (Capsicum annuum L.) seedlings under salt stress.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:17.691093+00:00"}
{"study_id": 3710, "supplement_id": 926, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether glycine betaine (GB) supplementation could enhance Spirulina's biomass yield and resistance to lead toxicity under high CO2 conditions.", "results_summary": "GB supplementation significantly reduced lead accumulation (39.7% extracellularly, 60.7% intracellularly) and decreased extracellular dissolved organic matter, while also strengthening osmotic stress responses and suppressing metal ion transport.", "population_specificity": "Spirulina (microalgae) under high CO2 and lead exposure conditions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:04:18.288204+00:00"}
